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Three diterpenes of the abietane class, 7β-acetoxy-6β-hydroxyroyleanone (I), 6β,7β-
dihydroxyroyleanone (II) and ent-pimara-8(14),15-diene-3β,11α-diol (III) and three 
triterpenes, 2α,3α,19α-trihydroxyurs-12-en-28-oic acid (IV), stigmasterol (V) and lupeol (VI) 
were isolated from the stem and leaf material of Plectranthus hadiensis.  The structures of the 
compounds were elucidated using 2D NMR spectroscopy and Mass spectrometry.  All six 
compounds have been isolated previously, but this is the first occurrence of compounds III-VI 
in Plectranthus hadiensis.   This is also the first report of the isolation of a pimarene from 
Plectranthus, which provides a biochemical link to other genera in the family Lamiaceae where 
this class of compounds exist.   
 
Compounds I to IV were tested for their antibacterial activity against Enterococcus faecalis and 
Pseudomonas aeruginosa as well as their anticancer activity against breast (MCF-7), renal (TK-
10) and melanoma (UACC-62) cell lines. Compounds I and II exhibited good antibacterial 
activity against Enterococcus faecalis and Pseudomonas aeruginosa and although the ent-
pimara-8(14),15-diene-3β,11α-diol (III), was inactive against E. faecalis, it was very active 
against P. aeruginosa.  Compound IV, the triterpenoid, was structurally different to I-III and 
did not show any anti-bacterial activity.  Compounds I-III were weakly active toward the 
cancerous renal (TK-10), melanoma (UACC-62) and breast (MCF-7) cell lines, while IV was 
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Chapter 1 Introduction to diterpenoids 
1.1 Classification of diterpenoids 
Diterpenes consist of four isoprene units (C20) and are by far the most diverse group of 
compounds.  They are placed into different classes (termed acyclic, monocyclic, bicyclic, 
tricyclic, tetracyclic and macrocyclic) based on the number of carbocyclic rings in the 
structure (figures 1a-d).   
 
The acyclic and monocyclic compounds (figure 1a) do not have much variation in that 
they are either straight chain structures or contain one ring and a side chain respectively, 
such as phytane (1) and vitamin A (2). 
 
Bicyclic compounds belonging to Class 3 (figure 1a), contain two six-membered 
carbocyclic rings with alkyl groups attached at either C-8 or C-9 or both.   Labdanes and 
clerodanes are differentiated because of the different positions of the methyl groups.  In 
clerodanes these methyl groups occur at C-4, C-5, C-8, C-9 and C-13 while in labdanes 
there are two methyl groups at C-4 and one each at C-8, C-10 and C-13. 
 
Class 4 diterpenes (figure 1b) are the tricyclic diterpenoids and have three six-membered 
rings but differ in the substitution pattern on these rings.  Abietane and totarane 
diterpenoids are fairly similar in structure, the only difference being the position of the 
isopropyl group in ring C, which is situated at C-13 in abietanes and C-14 for totaranes 
due to different alkyl shifts, abietane being the precursor to totarane (Dewick, 2002; 
Nakanishi, 1974).   
 
The structural difference between pimarane and cassane type diterpenes is the position of 
the methyl group (CH3-17) on ring C, which occurs at C-13 in pimaranes and C-14 in 
cassanes, pimarane being the precursor to the cassanes (Nakanishi, 1974) and occurs by a 
methyl shift from C-13 in the pimaranes to C-14 in the cassanes when a carbocation at C-




compounds are also classified as tricyclic, but have a different biosynthetic pathway 
(Dewick, 2002). 
 
Within the class 5 diterpenoids (figure 1c), the kauranes, beyeranes and atisanes are all 
derived from the sandaracopimarenyl cation.  This is shown later in figures 10 and 11.  
They are therefore similar in structure, the kauranes having a methylene group at C-16, 
the beyeranes having a methyl group at C-17 and the methylene bridge occurring 
between C-12 and C-8 in the atisanes.  The gibberellins are similar to the kauranes, the 
difference being the five-membered ring in gibberellins arising from the biosynthesis 
(Figure 10).  Phorbols and ginkolides follow different biosynthetic pathways (Dewick, 
2002).   
 
The macrocyclic compounds (figure 1d), the trachylobanes and the aconanes, are similar 














































(3) 15-hydroxy-3-cleroden-2-one (clerodane) (4) Forskolin (labdane) 
Figure 1a: Acyclic (class 1), monocyclic (class 2) and bicyclic (class 3) diterpenes 






















































   
Figure 1c: Tetracyclic (Class 5) diterpenes 


























































(5) Horminone (abietane) (6) Totarol (totarane) (7) Phytocassane E (cassane) 

















































(9) Taxusin (taxane) (10) 3β,12-dihydroxy-13-methyl-
5,8,11,13-podocarpatetraen-7-one 
(podocarpane) 
   

























































(14) GA19 (gibberellin) (15) phorbol (16) Bilobalide (ginkgolide) 
   



















































(17) hydroxytrachylobanic acid (trachylobane) (18) aconane 
  




1.2 Classification of the abietane diterpenoids 
Abietane diterpenoids consist of approximately twenty carbon atoms and commonly have 
three tertiary methyl groups (two at C-4 and one at C-10), and one isopropyl group at C-
13.  Their numbering system is based on the nomenclature of natural product hydrides as 
recommended by the I.U.P.A.C. in 1993 (Figure 3).  These abietanes can be further 
classified into eight types based on structural differences through reductions (addition of 
hydrogen across a double bond) or oxidations such as hydroxylations and dehydrations as 
























Figure 3: Numbering system for abietanoids 
 
Acidic abietanes (e.g. abietic acid (19), figure 4) are characterised by the presence of a 
carboxylic acid in the compound.  In levopimaric acid (20) there is a double bond in ring 
C (figure 4). In ferruginol (21) and carnosol (22) type abietanes, ring C is phenolic in 
character.  Due to the presence of a lactone ring which extends across ring B from C-7 to 
C-10, carnosol type abietanes are differentiated from ferruginol type abietanes. 
  
Callicarpone (23) abietanes are based on the epoxide ring at ∆12 and the presence of a 
hydroxy isopropyl group attached to C-15 as well as α,β-unsaturated ketone groups in 
rings B and C.  The royleanones (24) have a benzoquinone ring C.   Tanshinone (25) 
abietanes consist of highly oxidised rings where two of the rings, A and B are aromatic, 
ring C contains two adjacent α,β-unsaturated systems and a fourth ring, a furan ring is 




may be referred to as a norabietane due to the absence of the methyl group at C-4. Also 


















(19) abietic acid (20) levopimaric acid (21) ferruginol 
























(22) carnosol (23) callicarpone (24) royleanone 











(25) tanshinone (26) dl-fichtelite  
   
Figure 4: Representative structures of the different types of abietane diterpenoids 
(Nakanishi et al., 1974) 
 
 
The terms “nor”, “abeo” and “seco” are used widely in the abietanes.  The use of “nor” 
occurs when a methyl group is eliminated from the structure.  The number preceding 




when a methyl group migrates to an adjacent carbon atom and “seco” refers to a bond 
that has been broken on the skeletal structure.  The numbers preceding “abeo” refers to 
the carbon atoms involved in the migration e.g. (10→5) abeo indicates that a methyl has 
migrated from C-10 to C-5 and the numbers preceding “seco” refers to the carbon atoms 
in which the bond has been broken e.g. in 4,5-seco the bond has been broken between C-




























(a) 18-nor (b) 4,5-seco-20(10→5)abeoabietane 
  





The acyclic diterpenes (Class 1), for example phytane (1) (Figure 1a) is formed by the 
addition of four molecules of IPP (isopentenyl diphosphate).  The formation of IPP can 
follow either one of two biosynthetic pathways, the methylerythritol phosphate pathway 
(MEP), also known as the 1-deoxy-D-xylulose (DOX) pathway and the mevalonic acid 
(MVA) pathway. The MVA pathway is the only pathway used by animals, while both 
pathways are present in plants. The enzymes involved in the MVA pathway are found in 






 In the mevalonic acid pathway, the biosynthesis starts with the Claisen condensation 
reaction where two molecules of acetyl-CoA react to produce acetoacetyl-CoA which 
reacts further with an additional molecule of acetyl-CoA in a stereospecific aldol reaction 
producing HMG-CoA (β-hydroxy-β-methylglutaryl-CoA) (figure 6).  The carbonyl 
group in HMG-CoA is then reduced with NADPH to the primary alcohol producing 
mevaldic acid hemithioacetal, then mevaldic acid and further reduction to mevalonic acid 
(MVA). The addition of two ATP molecules leads to the sequential phosphorylation of 
MVA to mevalonic acid diphosphate and a further molecule of ATP results in the release 
of CO2 producing isopentenyl disphosphate (IPP) which is subsequently isomerised to 
DMAPP in a reversible reaction.  The forward reaction is favoured due to the 





















































































In the MEP pathway, 1-deoxy-D-xylulose-5-phosphate is derived from pyruvic acid.  
Thiamine diphosphate bonds to the pyruvic acid, which leads to decarboxylation 
producing a TPP/pyruvate enamine which then reacts with D-glyceraldehyde, followed 
by the loss of TPP to yield 1-deoxy-D-xylulose 5-P (DXP).  DXP undergoes a pinnacol 
like rearrangement followed by a reduction to produce 2-methyl-D-erythritol 4-P.  This is 
then transformed into 4-(CDP)-2-methyl-D-erythritol due to its reaction with cytidine 
triphosphate (CTP) and then phosphorylated with ATP.   Cyclisation involving the 
oxygen of the terminal phosphate group with the phosphorus of the cytidine bound 
phosphate results in a phosphoanhydride. Opening of the ring and subsequent reduction 









































































































































IPP DMAPP  
Figure 7: IPP derived from deoxyxylulose phosphate (DXP), (reproduced from 
Dewick, 2002) 
DMAPP contains a diphosphate anion which acts as a good leaving group resulting in the 
isoprene unit being electrophilic.  DMAPP yields an allylic cation by means of a SN1 
reaction.  IPP then adds to this allylic cation and with a stereospecific loss of a proton 
(HR) which then forms geranyl pyrophosphate (GPP).  Addition of two further IPP 
molecules result in the formation of first farnesyl diphosphate (FPP) and then 























Figure 8:  Derivation of GGPP from DMAPP (reproduced from Dewick, 2002) 
 
Monocyclic diterpenes e.g. vitamin A (2) are formed via the first cyclisation step after the 
formation of GGPP, which is initiated by the protonation of the isopropylidene unit in 













Figure 9: Formation of ring A from GGPP 
 
A series of cyclisations as in figure 10 yields the bicyclic intermediate, copalyl 
diphosphate.  The subsequent loss of pyrophosphate and cyclisation of copalyl PP results 
in the formation of the tricyclic diterpenes as in the sandaracopimarenyl cation 
(intermediate I).  Attack by the double bond on the carbocation in the 
sandaracopimarenyl cation results in a fourth ring (intermediate II).  Stabilisation of the 




in the kauranes.  From the kauranes, loss of a hydride ion in ring B followed by ring 
contraction and further oxidations result in the gibberellins (figure 10) (Dewick, 2002).   
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Figure 10:  Biosynthetic pathway for bi-, tri- and tetracyclic diterpenes (reproduced 
partially from Dewick (2002), Nakanishi (1974) and Hanson (1968)) 
 
Loss of a proton at C-16 (in intermediate I) with retention of the methyl at C-13 would 
lead to the beyeranes (figure 11). Formation of a carbocation at C-12 from intermediate II 
followed by an alkyl migration of the methylene bridge gives rise to the atisane type 
compounds (Figure 11).  The macrocyclic type compounds, the trachylobanes and 
aconanes form pentacyclic and tetracyclic diterpenes respectively.  The bond between C-
12 and C-15 is formed with loss of a proton producing the trachylobanes and 
rearrangement of the 8,9 bond to the 9,16 position with loss of the C-17 methylene group 
























































































Figure 11:  Biosynthesis of beyerane, trachylobane, atisane and aconane diterpenes 
(Manitto, 1981) 
 
The loss of a proton at C-14 in the sandaracopimarenyl cation leads to the formation of a 
double bond between C-8 and C-14 after which a methyl migration from C-17 to C-15 
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Chapter 2    An introduction to the Plectranthus in South 
Africa 
2.1 Phylogeny, occurrence and description 
The genus Plectranthus is one of twenty-five genera in the subfamily Nepetoideae of the 
family, Lamiaceae.  Plectranthus is an “Old World” genus belonging to the Mint/Sage 
family.  It contains about three-hundred species found in tropical Africa, Asia, India, 
Madagascar, Australia and a few Pacific islands (Rijo et al., 2007; Lukhoba et al., 2006; 
van Jaarsveld, 2006). The name Plectranthus literally means ‘spur flower’ due to the 
characteristic spurred corolla tube present in the first Plectranthus species that was 
discovered.  This physical attribute however, is not consistent throughout the genus and 
may easily be confused for belonging to the Solenostemon or Thorncroftia species. 
 
Within Africa, Plectranthus can be found in the southern part for example, Namibia, 
Swaziland, Lesotho and South Africa.  It grows abundantly in eight out of the nine 
provinces within South Africa, with the largest concentration being found in the north-
eastern part of the Eastern Cape and southern KwaZulu-Natal which has as much as 
thirty-six species.  Plectranthus is desirable as a garden plant because it suppresses weed 
growth and prevents erosion (van Jaarsveld, 1988) and is simple and inexpensive to 
maintain.  It is also of ornamental interest and is cultivated for their attractive foliage.  
They are however susceptible to attack by the eel-worm which, if not treated 
appropriately can lead to complete deterioration of the plant (van Jaarsveld, 1988).   
 
They are usually found growing in shade under trees where the soil is rich in humus and 
well drained.  However, not all Plectranthus species thrive under these conditions.  
Species with succulent leaves prefer growth in drier regions such as the dry bushveld or 
in rockeries (Figure 13).  Even though Plectranthus species perish or wilt under extreme 
weather conditions such as frost and heat, they recover relatively quickly after a shower 





The flower colour varies among the species in Plectranthus, either being white, blue or 
mauve to pink.  At the end of February, the plants begin to develop flowerbuds and reach 
full bloom between March and April.  While some species of Plectranthus grow as 
upright shrubs to a height of approximately 1.5 meters, for example, ecklonii, fruticosus 
and hadiensis, others occur as groundcover plants, varying between 10 to 30 centimetres 
in height, for example madagascariensis and saccatus.  Plectranthus hadiensis can be 
easily identified because of its large, hairy leaves.   
 
 
Figure 13: Plectranthus hadiensis (picture courtesy of Prof. N. Crouch) 
 
Species of Plectranthus are used as ornamental, economic and medicinal plants.   
 
The phylogeny of Plectranthus was well documented by Paton et al. (2004) and Lukhoba 
et al. (2006) based on its DNA sequence and augmented morphological data of the genus.  
This information was presented in the form of a cladogram (figure 14) which divided the 
Plectranthus genus into two clades or groups.  Clade 1 contains Plectranthus species 
formally known as Coleus and are grouped together based on their 
ethnobotanical/medicinal uses with Clade 1b containing a greater number of medicinally 
active species than Clade 1a.  The groups in bold in figure 14 all have reported medicinal 




followed by subclade 2 and lastly subclade 1a where only groups 2 and 8 are used 
medicinally.  Species within Clade 1 are also sources of food and are used as food 
flavourants, fodder for domestic animals, ornamental displays in homes and gardens as 
well as other uses such as building material (Lukhoba et al., 2006).  For example, the 
wood from Plectranthus insignis can be used to build huts or temporary houses (Cheek et 
al., 2000; Lukhoba et al., 2006). 
 
There are further species that fit into clades 1 and 2 but could not be placed into any of 
the subclades as they were morphologically different species within these subclades.  
These are listed as unplaced groups A-E in each clade.   
 
Plectranthus is a synonym for Coleus (Lukhoba et al., 2006) and therefore in searching 
the literature for phytochemical reviews of Plectranthus, one has to also consider the 
Coleus species.  Plectranthus amboinicus itself has synonymns of Plectranthus 
aromaticus Roxb., Coleus aromaticus Benth. and Coleus amboinicus Lour. (Lukhoba et 
al., 2006).   
 
Beside morphological characteristics and DNA sequencing, it would also be useful to 
have chemotaxonomic data linking the different species together and hence, 
phytochemical studies on the different species of Plectranthus is important to build up a 






Group A: Plectranthus melleri (P. luteus)
P. esculentus
Group B: P. edulis, P. punctatus
Group C: P. lactiflorus, P. stachyoides
Group D: P. gracillimus
Group E: P. mollis, P beddomei
Clade 1 unplaced groups
Group 1: Pycnostachys
Group 2: Plectranthus sylvestris, P. alpinus,
P. defoliatus, P. insignis, P. decurrens
Group 3: P. robustus, P. baumii, P. foliatus,
P. katangensis, P. insolitus
Group 4: P. thysoideus, P. daviesii, P. sereti
Group 5: P. glabratus, P. parishii
Group 6: Anisochilus, Leocus africanum
Group 7: P. helfleri, P. albicalyx
Group 8: P. hadiensis, P. grandidentatus,
P. madagascariensis, P. argentatus,
P. parvifolius, P. congestus
P. graveolens, P. asirensis
Group 9: P. calycinus, P. rehmanii
Group 1: Plectranthus  igniarus
Group 2: P. tetensis, P. barbatus, P. kivuensis,
P. lanuginosus, P. caninus
Group 3: P. coeruleus
Group 4: P. fredericii, P. hereroensis
Group 5: P. bojeri, P. rotundifolius, P. vettiveroides,
Group 6: P. buchananii
Group 7: P. montanus, P. prostratus,
P. occidentalis, Plectranthus sp. aff
occidentalis, P. variifolius
P. pseudomarruboides, P. lanceolatus
Group 8: P. aegyptiacus, P amboinicus
Group A: Plectranthus adenophorus,
P. modestum
Group B: P. longipes
Group C: P. gracilis
Group D: P. pulcherissima
Group E: P. pubescens, P. radiatus
 
P. viphyensis
Clade 2 unplaced groups Group 1: Tetradenia
Group 2: Thomcroftia
P.ambiguus, P. zuluensis, P. parvus
Group 3: Plectranthus elegans, P. fruticosus,
P. ciliatus, P. oertendahlii, P. saccatus
Group 4: Aeollanthus
Group 5: Capitanopsis, Dauphinea, Madlabium
Group 6: Plectranthus glandulosus, P. longipes
 P. laxiflorus, P. kamerunensis, P. stolzii







represents groups cited as being useful represents groups with no/few cited uses Groups shown in bold have recorded medicinal uses
Figure 14: Illustration of the 2 clades within the Plectranthus species, categorized 












2.2 Ethnobotanical uses 
A comprehensive review was done by Lukhoba et al. (2006), which contains 
ethnomedicinal information of a variety of Plectranthus species between 1934 and 2005.  
This is summarised in tables 1 and 2 with additional information added for published 
work between 2006 and 2010.   
 
Table 1 is an inventory of Plectranthus species that are used by traditional healers to help 
alleviate and/or heal skin, digestive, respiratory, muscular-skeletal and genito-urinary 
conditions as well as infections, fever and pain, while table 2 contains an inventory of 
species used to treat heart, circulatory and blood disorders, ailments affecting the sensory 
and nervous system, treatment of poisonous substances in the body, inflammation and 
medical conditions which could not be assigned to any of the other categories, labelled as 
‘unspecific’.  
 
A total of twenty-one Plectranthus species are used for digestive conditions, nineteen 
used for skin conditions and sixteen and fifteen species respectively used for respiratory 
conditions and infections and fever (Table 1).  This in itself is evidence of the genus’ 
widespread use ethnomedicinally.   
 
The conditions listed in table 2 are not treated by as many species as are those listed in 
table 1 with the highest being eight species used for nervous conditions, followed by six 
species to treat sensory conditions, five species for heart, circulatory and blood disorders 
and four species each for treatment against poisons and inflammation. 
 
Plectranthus barbatus and Plectranthus amboinicus have proven to be the most widely 
used species, being used in all of the medical conditions listed in Tables 1 and 2 with 
Plectranthus laxiflorus being used in all conditions in table 1 and three of the categories 
as reflected in Table 2. 
 
It must be noted that digestive conditions as categorised by Lukhoba et al. (2006) contain 




different medical conditions and in many cases, the treatment of inflammation will also 
result in the relief of pain.  Respiratory and genito-urinary conditions could also lead to 
infection and fever.  It is thus unclear from the information presented in Lukhoba et al. 
(2006) or the papers cited therein whether or not the plant extracts are treating a certain 
condition or the symptoms arising from these conditions as pain and fever are the 
symptoms of a wide variety of diseases.  The same can be said about nausea, vomiting 
and diarrhoea.  They are the symptoms of a wide variety of viral and bacterial infections.   
 
Examples of heart, circulatory and blood disorders are congestive heart failure, 
hypertension and angina.  Epilepsy, convulsions and depression are related to the nervous 
system while ear and eye problems are grouped as ‘sensory’ conditions.  Poisons 
treatment refers to the treatment of a person who has been bitten or stung by an insect or 
animal which posesses venom.  
 
Even though in many instances, these ethnomedicinal uses are unsubstantiated and 








































(Forssk.) C. Chr 
       
P. alpinus (Vatke) 
O. Ryding 
       
P. ambiguus (Bolus) 
Codd 
       
P. amboinicus 
(Lour.) Spreng 
       
P. asirensis J.R.I 
Wood 
       
P. barbatus Andr.        
P. beddomei Raiz.        
P. bojeri (Benth.) 
Hedge 
       
P. caninus Roth        
P. coeruleus 
(Gurke) Agnew 
       
P. coleoides      
2
  
P. congestus R.Br.        
P. decurrens 
(Gurke) J.K. Morton 
       
P. defoliatus Hochst. 
Ex Benth 
       
P. eckonlii Benth        
P. edulis (Vatke) 
Agnew 
       
P. elegans Britten        
P. esculentus 
N.E.Br. 
       
P. fruticosus L’Her.        
P. glandulosus 
Hook.f. 
       









     
P. hereroensis Engl.        
P. ignarius 
(Schweinf.) Agnew 
       
P. insignis Hook.f.        
P. kamerunensis 
(Gurke) 
       
P. lactiflorus 
(Vatke) Agnew 
       
P. lanceolatus Bojer 
ex Benth 
       

























       
P. laxiflorus Benth.        
P. longipes Baker        
P. madagascariensis 
Benth. 
       
P. mandalensis 
Baker 
       
P. melleri Baker        




      
P. montanus Benth.        
P. parviflorus 
(Poir.) Henckel  
       




       
P. pubescens Baker        
P. punctatus L’Her        
P. rogosus       
3
  
P. stachyoides Oliv.        
P. stolzii Gilli        
P. sylvestris Gurke         
P. tetensis (Bak.) 
Agnew 
       
P. vettiveroides 
(K.C. Jacob) H.I 
Maass 
       
Total 19 21 16 15 7 10 6 
* Where data was not taken from Lukhoba et al. (2006) the references are denoted by superscripts in the table 
and the references are given below 
+
  No mention in the references cited within Lukhoba et al. (2006) to these conditions, however Lukhoba et al. 
(2006) lists these as being prevalent 
1
 Ayyanar and Ignacimuthu, 2005 
2
 Ignacimuthu et al., 2006 
3
























(Forssk.) C. Chr. 
      
P. alpinus (Vatke) 
O. Ryding 
      
P. amboinicus 
(Lour.) Spreng 
      
P. barbatus Andr.       
P. bojeri (Benth.) 
Hedge 
      
P. congestus R.Br.       
P. edulis (Vatke) 
Agnew 
      
P. fruticosus 
L’Her. 
      
P. glandulosus 
Hook.f. 
      
P. grallatus Briq.       
P. grandidentatus 
Gurke 









      
P. kivuensis 
(Lebrun & Touss.) 
R.H. Willemse 
      
P. laxiflorus 
Benth. 
      




      
P. mandalensis 
Baker 
      
P. mollis (Aiton) 
Spreng 
      
P. montanus 
Benth. 
      
P. occidentalis  
B.J. Pollard 
      
P. pubescens 
Baker 
      
P. punctatus 
L’Her 
      














P. sp. aff. 
occidentalis 
      
P. stolzii Gilli       
P. vettiveroides 
(K.C. Jacob) H.I 
Maass 
      
P. viphyensis 
Brummit & J.H. 
Seyani 
      
Total 5 8 6 4 4 18 
+
  No mention in the references cited within Lukhoba et al. (2006) to these conditions, however Lukhoba et 
al. (2006) lists these as being prevalent 
 
The modes of administration of the plant extracts differ according to the ailment being 
treated.  The treatment of skin conditions such as burns, wounds, allergies and insect 
bites are treated by applying ground plant material on the affected area whilst bathing in 
herbal extracts may help alleviate the irritation associated with measles and chicken pox. 
Digestive and respiratory conditions are treated by drinking teas, infusions or decoctions 
to alleviate constipation, indigestion and dyspepsia as well as asthma, bronchitis and 
other respiratory conditions and the inhalation of steam or smoke is used for the treatment 
of colds and influenza.  Enemas and injections are also used as a means of administering 
plant extracts to the patient (Gurib-Fakim, 2006).  For instance, the leaf infusion of 
Plectranthus defoliatus Hochst. ex Benth. is either drunk or admininstered as an enema 
(Neuwinger, 2000).  With regard to injections being administered, no information is 
given as to how the extracts are injected and whether they use conventional needles and 
syringes or home-made equivalents as there is doubt as to where and how traditional 
healers would get access to needles and syringes.  Furthermore, there is doubt as to 
whether traditional healers are trained to administer injections, and the improper use of 
needles and syringes, for example the repeated use of these could do the patient more 







2.3 Pharmacological/biological uses of the plant extract 
Extracts of Plectranthus species have shown to be active in a wide range of bioassays.  
These include antibacterial, antifungal, antiparastitic, anti-inflammatory, antioxidant, 
antitumour and insect antifeedant activity.  Of these, they find most widespread activity 
in antibacterial and antifungal assays.  References are given in the subchapters that 
follow. 
 
Methods used for the determination of antibacterial activity 
The two most common qualitative methods for testing antimicrobial activity of extracts 
are performed by either using the agar well assay or the disc diffusion assay.  In the agar 
well method, wells or holes are made into the solidified, sterile agar plate once the test 
inoculum has been evenly distributed on the agar surface.  These wells are then filled 
with solutions of the plant extracts and test controls. After incubation, the antimicrobial 
activity is determined by measuring the diameters of zones of inhibition in milimeters.   
 
In the disc diffusion assay, filter paper discs are dissolved in solutions of plant extracts 
and placed onto the inoculated plate.  Once incubation of the plate is complete the 
antimicrobial activity is determined by measuring the diameters of zones of inhibition in 
milimeters.  Wells or holes are not required for this method of testing.  Since the unit of 
measurement is the same for both test methods, results can be compared.  
 
The bioautography agar overlay method is derived from the disc diffusion assay/method 
and uses thin layer chromatography (TLC) plates instead of filter paper.  In this method 
the plant extract or compound of interest is adsorbed onto the TLC plate followed by the 
introduction of a thin layer of inoculum onto the very same plate.  The plant extract or 
compound being evaluated then diffuses from the TLC/adsorbent into the inoculum.  
After incubation of the TLC plate, the Rf values of the observed spots are recorded and 
zones of inhibition are measured in mm.  
 
All three methods described above, are performed in triplicate to ensure reproducible 




Use of the minimum inhibitory concentration (MIC) assay allows one to determine the 
lowest concentration at which an extract will be active.  This is normally represented in 
µg/ml and is carried out by serial dilutions of the plant extracts or compounds under 
study.     
 
Antibacterial activity of Plectranthus and Coleus plant extracts 
It is observed from Table 3 that the Plectranthus species are active against a variety of 
bacterial strains but being more active toward Staphylococcus and Bacillus species with 
sixteen of the twenty-one Plectranthus species being active against Staphylococcus 
aureus and Bacillus subtilis listed in table 3, below. Although the Pseudomonas bacterial 
strain was also a popular choice for antibacterial testing, only eight Plectranthus species 
was active against this pathogen.   
 
The leaves, roots and aerial parts were the most common parts of Plectranthus which 
have been tested for antibacterial activity with there being one report on the activity of 
the stems and the flowers against bacteria (Rabe and van Staden, 1998; Matu and van 
Staden, 2003).  In one study, the root and flower extracts displayed higher antibacterial 
activity than the leaf extracts (Rabe and van Staden, 1998; Matu and van Staden, 2003; 
Mothana et al., 2008) suggesting that further antimicrobial studies of the root and flower 
extracts in Plectranthus should also be carried out. 
 
The solvents used to prepare the extracts for bioassays, were predominantly polar with 
there being just two instances where hexane was used as the solvent medium.  Ideally, a 
high activity of the water extracts is desired as water is readily available, inexpensive and 
safe for human consumption.  An alternative to using solvents to prepare plant extracts 
for bioassays, is the hydrodistillation of the plant or certain parts of the plant producing 
an essential oil (Ascensao et al., 1998; Alsufyani et al., (see footnote X under table 3); 
Marwah et al., 2007; Oliveira et al., 2007; Vagionas et al., 2007).  This method however, 
excludes the secondary metabolites which are not volatile at the temperatures being used.  
The polar extracts are more active than the non-polar extracts at inhibiting the growth of 




P. barbatus and P. madagascariensis were the two most commonly tested plant species, 
with extracts from both plants being more susceptible to gram-positive bacteria 
(Staphylococcus aureus and Bacillus subtilis) than gram-negative bacteria (Ascensao et 
al., 1998; Rabe and van Staden, 1998; Matu and van Staden, 2003; Wellsow et al., 2006; 
Kisangau et al., 2007; Figueiredo et al., 2010).  Coleus kilimandschari was found to be 










































Bacillus cereus, Enterobacter 








Cos et al., 2002 






Wellsow et al., 
2006 











S. aureus, B. subtilis, E. coli,  
P. aeruginosa
 






(Streptococcus sobrinus and 
Streptococcus mutans) 








B. subtilis, S. aureus,  
Micrococcus luteus 


















S. aureus, B. subtilis 
Rabe and van 
Staden, 1998 P. ciliatus 
(1 collection) 





E. coli, P. aeruginosa, K. 
pneumoniae, S. aureus, B. 
subtilis, Salmonella 
choleraesuis 






Cariogenic bacteria (S. 
sobrinus and S. mutans) 




 S. aureus, B. subtilis 




S. aureus, B. subtilis,  
M. luteus, Staphylococcus 
epidermis 







medium and plant 
part/s used 





 B. subtilis, P. syringae 
Wellsow et al., 
2006 
P. fruticosus 
(2 different collections) 
methanol
lv
 S. aureus, B. subtilis 
Rabe and van 
Staden, 1998 
P. fruticosus  methanol
f
  






multi-resistant strains of S. 
epidermidis, 
Staphylococcus 
haemolyticus and S. 
aureus, the North German 
epidemic strain 








S. aureus, B. subtilis, 
Micrococcus flavus and 
multi-resistant strains of S. 
epidermidis, S. 
haemolyticus and S. 




 8 bacillus formulations 










S. aureus, Vibrio cholera, 
 Streptococcus faecalis 
Batista et al., 1994 
P. laxiflorus essential oil
a
  
S. aureus, S. epidermis, E. 
coli, E. cloacae, K. 
pneumoniae, P. aeruginosa 





 B. subtilis, P. syringae 





B. subtilis, *Micrococcus 
sp., S. aureus, Yersinia 
enterocolitica 
Ascensao et al., 
1998 
P. madagascariensis 




S. aureus, B. subtilis, 
 M. luteus, S. epidermis 
Rabe and van 
Staden, 1998 
P. oribiensis 
S. aureus, B. subtilis,  
M. luteus, S. epidermis 
P. oribiensis 
S. aureus, B. subtilis,  
M. luteus, S. epidermis 







medium and plant 
part/s used 
Antibacterial activity Reference 
P. ornatus essential oil
lv
 
S. aureus, S. pyogenes, 
 E. coli, S. typhimurium 
Oliveira et al., 2007 
P. petiolaris methanol
lv
  S. epidermis, B. subtilis 




 P. syringae 
Wellsow et al., 
2006 




S. aureus, B. subtilis, 
S. epidermis 
Rabe and van 
Staden, 1998 
*Plectranthus sp.  
(3 hybrids) 
S. aureus, B. subtilis 
*Plectranthus sp.  
(1 hybrid) 
S. aureus, B. subtilis, 
M. luteus 
*Plectranthus sp. 
 (1 hybrid) 
S. aureus, B. subtilis, 
S. epidermis 
P. strigosus 
S. aureus, B. subtilis, 
 M. luteus, S. epidermis 
P. tenuiflorus essential oil
lv
  
S. aureus, S. pyogenes, 




Alsufyani et al.,  
P. verticillatus methanol
lv
 S. aureus, B. subtilis,  
S. epidermis 
Rabe and van 
Staden, 1998 
NB. A species of Coleus is also included in this table because of the uncertain relationship to the 
Plectranthus species   
* Unknown species 
x
  available electronically on http://www.kau.edu.sa, date accessed 27/09/2010; the date of the publication 
is not apparent.  
Key: lv: leaves, rt: roots, s: stems, a: aerial parts, w: whole plant, f: flowers  
 
Table 4 contains antifungal activity of eight Plectranthus species and one Coleus species.  
All of the species in table 4 were active against at least one Candida species with six 
Plectranthus species being active against Candida albicans, the most widely tested 
fungal pathogen.  P. amboinicus and P. barbatus were the two most tested species for 
antifungal activity from all the Plectranthus species.   
 
From the studies reviewed, hydrodistillation seemed to be the most popular method of 
extraction, followed by solvent extraction with water, methanol and more uncommonly 




There were two comparative studies on the solvent extracts with regard to antifungal 
activity (Laing et al., 2006; Kisangau et al., 2007).  In one study, the ether extract showed 
higher activity than the dichloromethane and aqueous extracts while in the other study, 
the hexane extract was more effective than the dichloromethane extract.  This indicates 
that future studies on ether and hexane extracts need to be conducted since these extracts 
were shown to be active. 
 
The leaves are the most popular part of the plant used to make extracts for antifungal 
activity.  Other studies mention aerial parts being used for extraction but these parts are 
not specified and could be the leaves, flowers, seeds or fruit.  There is also one report on 
the roots being used.  There is thus a need for more studies on the roots and stem material 
to be carried out for antifungal activity as not many studies have been done on these plant 
parts. 
 
There is also a need for comparative studies to be done with the different plant parts as 
well as with the solvent used for extraction.  This would then provide a much clearer 
indication of which plant part as well as which solvent is best suited for antifungal 
activity and would be a good guide for phytochemists to use when choosing a suitable 






































Aspergillus flavus, Aspergillus 
niger, Aspergillus ochraceus, 
Aspergillus oryzae, Candida 
versatilis, Fusarium 
moniliforme, *Penicillium sp., 
Saccharomyces cerevisiae, in 
stored food commodities 




  Candida krusei   





C. albicans, Candida 
tropicalis, Candida 
guilliermondii, Candida krusei   





  Candida krusei   




  C. albicans 

















C. albicans, M. canis, 
Microsporum gypseum,  
T. rubrum, Trichophyton 
mentagrophytes 
Marwah et al., 
2007 
Inhibits fungal spore 
germination and growth of 
*Bipolaris sp., Alternaria 
alternate, Fusarium 




  Candida krusei   
Tempone et al., 
2008 



















Rhizoctonia solani, *Candida 
species  










  C. albicans, C. tropicalis,  
C. glabrata 




  Candida krusei   
Tempone et al., 
2008 
P. tenuiflorus essential oil
lv





NB. A species of Coleus is also included in this table because of the uncertain relationship to the 
Plectranthus species   
* Unknown species 
x
  available electronically on http://www.kau.edu.sa, date accessed 27/09/2010; the date of  the publication 
is not apparent.  
Key: lv: leaves, rt: roots, s: stems, a: aerial parts, w: whole plant, f: flowers  
 
Besides posessing antifungal and antibacterial activity, Plectranthus and Coleus species 
also have anti-tumor, antiparasitic, antioxidant, antifeedant and anti-inflammatory 
properties, as shown in Table 5a. 
 
P. amboinicus appears to be the most commonly used Plectranthus species, being active 
against a wide variety of pharmacological activities.  P. barbatus was also a popular plant 
species used, being active in three of the five pharmacological activities contained in 
table 5a.  Other Plectranthus species are used less frequently. 
 
The leaves seem to be the most popular plant part used to inhibit the growth of parasites, 
to act as an antioxidant and antifeedant as well as for the treatment of inflammation and 
tumors.  There has been only two reports on root extracts being used and just one report 
on the stem being used.  More research on the root, stem and aerial parts is required as it 






Methanol, ethanol and water seem to be used more frequently than hexane and acetone 
for making extracts to be tested in these bioassays.  There has been one report where 
hexane and acetone extracts were used.  This may limit the studies to polar extracts and 
more studies using hexane, dichloromethane and acetone is needed to ascertain whether 
the non-polar fractions are active in these same bioassays.    
 
Table 5a: Antiparasitic, anti-inflammatory, antioxidant, antitumour and insect antifeedant 











inhibits growth of 








chagasi and Leishmania 
amazonensis 







chagasi and Leishmania 
amazonensis 
Tempone et al., 
2008 
P. cylindraceus essential oil
a
 
nematicidal activity against 
Meloidogyne javanica 







chagasi and Leishmania 
amazonensis 
Tempone et al., 
2008 
P. marruboides essential oil
a, lv
 
toxic fumigant against 
Anopheles gambiae 






chagasi and Leishmania 
amazonensis 










ovicidal and larvicidal 
activity against 
Haemonchus contortus 
Tadesse et al., 
2009 



















Antiviral activity against 
DNA-virus Herpes simplex 
virus type 1 
Cos et al., 2002 
Antioxidant Activity 
P. amboinicus essential oil
lv
 antiradical activity  







confirmed by DPPH and β-
carotene/linoleic acid test 
assays 
















confirmed by DPPH and β-
carotene/linoleic acid test 
assays 
Fale et al., 2009 
P. laxiflorus essential oil
a
 antiradical activity 






confirmed by DPPH and β-
carotene/linoleic acid test 
assays 







Gurgel et al., 2009 











Matu and van 
Staden, 2003 




















ascite and Ehrlich ascite 
carcinoma) activity in mice 






Inhibits growth of 
carcinoma (HepG2, Huh7) 
and melanoma (Bowes) 
cells 








antifeedant activity against 
S. littoralis 







NB. The term ‘mixture’ refers to the testing of a composition comprising of a Plectranthus plant extract 
with either another plant extract/essential oil (not necessarily belonging to the Plectranthus species) or an 
appropriate pharmaceutical drug.   
Key: lv: leaves, rt: roots, s: stems, a: aerial parts, w: whole plant, f: flowers  
 
Plectranthus and Coleus species act as abortificients (Almeida and Lemonica, 2000), 
prevent the formation of plaque build-up on teeth (Figueiredo et al., 2010), are used 
topically as a barrier against harmful UV rays (Chen et al., 2009), act as a hair growth 
stimulant (Kiyoshi et al., 2005) and inhibitor (Kazuo et al., 2006), are used in the 
treatment of rheumatoid arthritis (Rey-Yuh et al., 2008; Jui-Yu et al., 2009), act as a 
scorpion venom antidote (Uawonggul et al., 2006) and are used to treat Alzheimers 
disease (Fale et al., 2009) as well as many other ailments, disorders and diseases (table 
5b). 
 
P. amboinicus and P. barbatus seem to be the most commonly tested species each having 
widespread application.  Once again the leaves appear to be the most popular plant part 
used.  There has been just one study on the root extract.  The stems and roots need to be 




There are plant extracts in table 5b which have been tested as mixtures either in 
combination with other plant extracts or pharmaceutical agents, which highlights the 
synergistic effect of various Plectranthus and Coleus species. 
 
Table 5b: Other important inhibitory activity of polar extracts from Plectranthus and 





Other Activities  Reference 









mixture prevents foul breath Sonoko et al., 2005 
C. foskohlii 
mixture 
prevention of progression 
of diabetic complications 
and skin aging 
Masayuki et al., 
2007 
antispasmodic effect on 
respiratory tract smooth 
muscle 
Rongqiu et al., 
2005 
treat all forms of obesity 
and associated metabolic 
syndromes 
Marcin et al., 2005; 
Han et al., 2005 
hair growth stimulant Kiyoshi et al., 2005 









expelling, treats acute and 
chronic bronchitis 




promotes longevity and 
increases bone mass and 
decreases body weight 




remedy for menopause 
disorder 






acts as scorpion venom 
antidote against 
Heterometrus laoticus 
Uawonggul et al., 
2006 
mixture treat rheumatoid arthritis Jui-Yu et al., 2009 
essential oil mixture 
relaxing uterus and 
alleviating dysmenorrhea 
Jiali et al., 2007 













treatment of skin disorders 
and healing of wounds 
especially in diabetic 
patients 
Rey-Yuh et al., 
2007 
essential oil mixture 
(applied on belly) 
Relieves menstrual pain 
by relaxing the uterus, 
tested in mice 
Chia-Li et al., 2007 
composition (taken 
orally or applied 
topically) 
Treat rheumatoid arthritis 
(tested in animals) 






helps in treatment of  
Alzheimers disease 
Fale et al., 2009 
water
lv
 prevents dental caries 







used topically as a 
mixture for UV 
protection.  Tested (in 
vitro) on human and 
guinea pig skin 





helps in treatment of  
Alzheimers disease 
Fale et al., 2009 
waterlv prevents dental caries 






helps in treatment of  
Alzheimers disease 
Fale et al., 2009 
essential oil (diethyl 
ether extract) 
antifertility activity by 
inhibiting implantations, 
in rats 





embryotoxic properties, in 
rats 
Pages et al., 1988 
P. grandis leaves 
possesses gastroprotective 
properties  





helps in treatment of  
Alzheimers disease 
Fale et al., 2009 
*Plectranthus 
species 
hot water  
increases blood vessel 
elasticity in stroke prone 
rats 
Tetsuji et al., 2007 
P. striatus mixture 
promotes function of 
gallbladder 
Yaoliang et al., 
2006 










Other Activities Reference 
P. ternifolius mixture 
treat liver function 
impairment 
Guo et al., 2006 
P. verticillatus aqueouslv 
helps in treatment of  
Alzheimers disease 
Fale et al., 2009 
NB. Coleus species are also included in this table because of the uncertain relationship to the Plectranthus 
species   
* Unknown species 
Key: lv: leaves, rt: roots, s: stems, a: aerial parts, w: whole plant, f: flowers  
 
 
2.4 The phytochemistry of Plectranthus 
The main phytochemical constituents of Plectranthus are diterpenoids, with about one-
hundred and forty-seven of these compounds being isolated from the coloured leaf-glands 
of Plectranthus species, the majority of which were highly modified abietanoids.  
Essential oils, monoterpenoids, sesquitepenoids and phenolics have also been isolated 
from Plectranthus species (Abdel-Mogib et al., 2002; Lukhoba et al., 2006).   
 
Compounds 27 to 174 are grouped into five categories, the royleoanone-type abietanes 
(compounds 27 to 69), the spirocoleons (compounds 70 to 108), vinylogous quinones 
(compounds 109 to 130), coleon-type abietanes (compounds 131 to 167) and the 
miscellaneous abietanes (compounds 168 to 174) which do not resemble any of the 
abietanes in the previous four categories.   
 
Twenty royleanone type abietanes with the presence of a hydroxybenzoquinone or p-
quinoid ring C system and an isopropyl group at C-13 have been isolated from eleven 
known Plectranthus species and three Coleus species (Table 6a).  These compounds all 
have methyl groups at C-4 and C-10 with the exception of compound 42 where the 
methyl group at C-10 is oxidized to an alcohol.  Compound 45 is notably different from 
compounds 27 to 46, as the substituent at C-12 is an acetyl group.  At C-6 and C-7 of 
compounds 27 to 42, there are either hydroxy, aldehyde or acetyl groups attached to these 




variation is observed within ring B with a double bond being present either at the ∆5 or ∆6 
positions.  Compound 46 has an epoxide ring in place of the olefinic bond at ∆8. 
 
Table 6a: Royleanone-type abietanes with an isopropyl side chain at C-13, isolated from 
Plectranthus and Coleus species  
Compound Name Synonym 
Isolated from 
Plectranthus (P) or 










Gaspar-Marques et al., 
2006; 
Cerqueira et al., 2004; 
Yoshizaki et al., 1979; 











Gaspar-Marques et al., 
2006; 
Batista et al., 1994; 
Yoshizaki et al., 1979; 


































Gaspar-Marques et al., 
2006; 
Yoshizaki et al., 1979; 
Matloubi-Moghadam et 
al., 1987 
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Compound Name Synonym 
Isolated from 
Plectranthus (P) or 














 P. edulis; 
P. hadiensis; 
P. fasciculatus 
Gaspar-Marques et al., 
2006; 
Gaspar-Marques et al., 
2002; 
Cerqueira et al., 2004; 
Yoshizaki et al., 1979; 
Alder et al., 1984a; 
Hensch et al., 1975; 
Matloubi-Moghadam et 
al., 1987; 
 Kunzle et al., 1987; 
















Cerqueira et al., 2004; 

















Teixera et al., 1997; 
Gaspar-Marques et al., 
2006; 
Gaspar-Marques et al., 
2002; 
Cerqueira et al., 2004; 
Yoshizaki et al., 1979; 
Alder et al., 1984a; 
Hensch et al., 1975; 
Mehrotra et al., 1989; 
Matloubi-Moghadam et 
al., 1987; 



















Miyase et al., 1977a; 
Alder et al., 1984a; 











Compound Name Synonym 
Isolated from 
Plectranthus (P) or 









































Gaspar-Marques et al., 
2006; 
Yoshizaki et al., 1979; 












Wellsow et al., 2006; 
Mei et al., 2002; 



















Mei et al. 2002; 





















































 R1 R2 
(27)  H H 
(28)  H α-OH 
(29)  H β-OH 
(30)  H α−ΟCΗ(Ο) 
(31) H α-OC(O)CH3 
(32)  OH H 
(33) OH α-OH 
(34)  OH β-OH 
(35) OH Fatty acid ester 
(36) OH α-OC(O)CH3 
(37)  OH β-OC(O)CH3 
(38) OH α-OCH(O) 














































 R1 R2 
(44) OH CH3 




Seven compounds 47 to 53 consisting of two abietane compounds joined either by 
oxygen or directly by carbon atoms from C-7 in one abietane to C-11' and C-12' (as in 
compound 47) or to C-7' and C-14' (as in compound 51) in the other have also been 
isolated from Plectranthus species.  These have been isolated from P. grandidentatus, P. 




compounds (Table 6b).  Depending on the orientation at C-7 and how this carbon atom 
joins to the next abietane, isomers result as in compounds 47 and 48; 49 and 50; and 51 
and 52.  Compound 53 is a dimer joined at C-7 of both compounds.  These compounds 
are difficult to name systematically and therefore only the common names are given in 
Table 6b.   
 
Table 6b: Royleanone-type abietane dimers isolated from Plectranthus and Coleus 
species 
Compound Common name 
Isolated from 
Plectranthus (P) 
or Coleus (C) 
species 
Reference 
47 Grandidone A 
P. grandidentatus; 
P. sanguineus 
Cerqueira et al., 2004; 
Gaspar-Marques et al., 
2002 




Uchida et al., 1981; 
Matloubi-Moghadam et al., 
1987 
49 Grandidone B 
50 7-epigrandidone B 
51 Grandidone D P. grandidentatus; 
P. myrianthus; 
C. carnosus 
Uchida et al., 1981 52 7-epigrandidone D 



































































































































(51) (52) (53) 
 
 
Seventeen compounds with linear side-chains at C-13 instead of the isopropyl group, 
compounds 54 to 69 were isolated from P. hereroensis, P. edulis, P. lanuginosus, P. 
sanguineus and C. coerulescens (Table 6c).  P. lanuginosus yielded the highest number 
of compounds compared to the other species which yielded less than five compounds.  
The side chains are either saturated as in 54, contain a double bond as in compounds 55-
63, an acetyl group as in compound 64 or an alcohol as in compounds 65, 68 and 69.  
Compounds 57 and 61 and 65-69 have functional groups at C-3 with 66-69 being abeo-






Table 6c: Royleanone-type abietanes with a linear side chain at C-13 isolated from 
Plectranthus and Coleus species 
Compound Name Synonym 
Isolated from 
Plectranthus 






 P. hereroensis 
Gaspar-Marques et 
al., 2006; 





 P. hereroensis 
Gaspar-Marques et 
al., 2006; 



































P. edulis;  
P. lanuginosus 
Kunzle et al., 1987; 























 P. hereroensis Batista et al., 1995 





















































(54)  R1 R2 
(55) H H 
(56) H OH 
(57) OCH(O) OH 
 
 R1 R2 
(58) CH(O) H 
(59) H C2H5 
 
   
Compound Name Synonym 
Isolated from 
Plectranthus (P) 
















 P. grandidentatus 
Gaspar-Marques 






 P. edulis 


































































 R1 R2 
(60) H H 
 (61) OCH(O) H 
(62)  H OH 
(63)  H OCH(O) 
 
(64) (65) 


































(66)  R1 R2 
(67) H CH2CH=CH2 
(68) H CH2CH(OH)CH3 





Thirty-eight compounds 70-108, commonly referred to as spirocoleons were isolated 
from P. edulis (eleven compounds), C. garckeanus (nine compounds), P. lanuginosus and 
C. coerulescens (seven compounds), C. barbatus (three compounds), P. grandis and C. 
somaliensis (two compounds) and P. barbatus (one compound) (Table 7).  These 
compounds are refered to as spirocoleons as C-13 is the common carbon atom which 
links the cyclopropyl ring to the coleon-type abietane.  The cyclopropyl bridge is 
represented as being either in the α or β position with the methyl group at C-15 being 
oriented such that the molecule is either R or S with respect to C-15.  In compounds 71-
82, R1 to R4 have either hydrogen, acetyl or formyloxy groups.  The difference between 




functional groups occur at C-6 and C-7, with C-6 being predominantly hydroxyl.  
Compound 100 is the only compound which has an acetyl group present at C-17.  
 
Table 7: Spirocoleons isolated from Plectranthus and Coleus species 
Continued on next page…. 
 
Compound Name Synonym 
Isolated from 
Plectranthus 




*cannot be conventionally named due to 




Zelnik et al., 1977; 








Schmid et al., 1982; 





































formyl coleon Y 











desacetyl) coleon R 
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Compound Name Synonym 
Isolated from 
Plectranthus (P) or 












































Zelnik et al., 1977; 































Moir et al., 1973b; 







desacetyl) coleon N 
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Compound Name Synonym 
Isolated from 
Plectranthus 












Moir et al., 1973b; 

























































































Compound Name Synonym 
Isolated from 
Plectranthus 








Coleon O C. garckeanus 







19-acetyloxy coleon O 
C. garckeanus 















 P. edulis 











Miyase et al., 
1979; 









































(70)  R1 R2 R3 R4 
(71)  H H H H 
(72)  H H H CH(O) 
(73)  H OH H CH(O) 
(74)  H OCH(O) H H 
(75)  H OCH(O) H CH(O) 
(76) OCH(O) H H H 
(77) OCH(O) H H CH(O) 
(78)  OCH(O) OC(O)CH3 H H 
(79)  OCH(O) H C(O)CH3 H 
(80) OC(O)CH3 H H H 
(81)  OC(O)CH3 H C(O)CH3 H 


































 R1 R2 R3 R4 
(83)  H H CH(O) H 
(84)  H H C(O)CH3 H 
(85) OCH(O) H CH(O) H 
(86) OCH(O) C(O)CH3 H C(O)CH3 
 
 R 
(87)  =O 











































 R1 R2 R3 
(91)  α-CH3 H H 
(92)  β-CH3 H H 
(93)  α-CH3 C(O)CH3 H 
(94)  β-CH3 C(O)CH3 H 
 (95) α−CH3 H C(O)CH3 
 (96) α−CH3 CH(O) H 
 (97) α−CH3 CH(O) C(O)CH3 
























































































 R1 R2 R3 R4 R5 
(100)  H C(O)CH3 H β-OH OC(O)CH3 
(101)  OC(O)CH3 C(O)CH3 H α-
OC(O)CH3 
H 
(102)  OC(O)CH3 H C(O)CH3 α-OH H 
(103) OC(O)CH3 H C(O)CH3 β-OH H 
 
 R 
(104)  H 










































Twenty-two quinone methides, 109-130 were isolated from ten Plectranthus species 
(Table 8).  Eight compounds were isolated from P. strigosus and six from P. lanuginosus 
and P. parviflorus while the other species yielded less than four compounds each.  
Compounds 109-120 closely resemble benzoquinones, but there is only one carbonyl 
present in ring C, located at C-12 instead of C-11 and C-14 and has double bonds at ∆7, 
C-9(11) and ∆13.  Compounds 121-130 have an additional double bond in ring B at ∆5.   
 
Yet again variation of the isopropyl group at C-13 is observed in compounds 109-117.  In 




reduced furan ring.  The linear side chains which have replaced the isopropyl group are 
either saturated as in 112, oxidized to a double bond as in compound 116 or contain 
methoxy groups (114) and hydroxy groups (111, 112, 115, 117, 119-122).  The tertiary 
methyl group usually present at C-19, has been oxidized to a formyloxy (-OCHO) group 
in compounds 114 and 117.  In abietanes 126-130 the methyl group at position 19 has 
been modified to include either an aromatic group as in 126-129 or a prenylated group as 
in 130.  Compound 122 has an acetyl group present at C-3 as well as a hydroxy group at 
C-15 while compounds 123-125 have aromatic substituents at C-2. 
 
Table 8: Vinylogous quinones isolated from Plectranthus species 
Continued on next page….. 
 
 






















Schmid et al., 
1982; 
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*Too complex to name 
systematically 
Nilgherron A 
P. nilgherricus Miyase et al., 
1977b 
120 
*Too complex to name 


















P. strigosus;  
P. eckonlii; 
P. lucidus 
Ruedi et al., 1978; 
Alder et al., 1984b; 
van Zyl et al., 








P.  parviflorus; 
P. strigosus; 
P. eckonlii 
Narukawa et al. 
2001; 
Ruedi et al., 1978; 
Alder et al., 1984b; 
van Zyl et al., 
2008; 


















Ruedi et al., 1978; 
Alder et al., 1984b; 






























Narukawa et al. 
2001;  
Ruedi et al., 1978; 
Alder et al., 1984b; 









Ruedi et al., 1978; 












































(109)  R 
(110)  CH3 
(111)  CH2(OH) 
 
 R 
 (112)  H 
 (113) C(O)CH3 
 






































(114)  R 
(115)  CH2CH(OH)CH3 
(116)  CH2-CH=CH2 
 
(117) 


















































(121)  H 





(123)     OC OH
O
R  =














(126)   R  =       OC(O)CH=(CH3)2    
(129) R  = OC OH
OCH3
O
(127) R  = OC OH
O



























Thirty-six compounds (131-167) having a coleon-type structure were isolated from 
eleven Plectranthus and ten Coleus species, where most of the compounds have been 
isolated from P. edulis and C. coerulescens (Table 9a-c).  The coleon-type compounds 
differ from the royleanones in that ring C is aromatic in coleon-type compounds as 
apposed to having a hydroxybenzoquinone or p-quinoid ring system.   
 
Compounds 131-148 (Table 9a) differ in ring B with regard to positions 6 and 7 as they 
both could be saturated as in 131, or oxidized, with either a hydroxy or carbonyl group 
(132-135) or two carbonyl groups (136-145).  Alternatively either C-6 or C-7 could be 
oxidized as in 132-134.  Compounds 138 to 141 are the only compounds where the 
methyl group/s at C-15 have been oxidized to an alcohol or acetyl group, while 134 is the 
only compound where the methyl group at C-20 has been oxidized to an alcohol.  
Plectranthol B (131), has an aromatic substituent at C-19 with a prenyl group occurring at 
C-12.  In compounds 146 to 148, an oxygen bridge is formed between C-20 and either C-
6 or C-7.  Compound 147 has a methoxy group present at C-20 while 148 has a carbonyl 
function at C-7.  
 
Table 9a: Coleon-type abietanes isolated from Plectranthus and Coleus species 
Compound Name Synonym 
Isolated from 
Plectranthus 








Plectranthol B P. nummularius 





















Horvath et al., 
2004;  








Alder et al., 
1984a 




Compound Name Synonym 
Isolated from 
Plectranthus 












Miyase et al., 
1977a; 
Yoshizaki et al., 
1979; 
Grob et al., 1978; 
Matloubi-


















Ruedi et al., 1972; 
Grob et al., 1978; 
Schmid et al., 
1982; 











Grob et al., 1978; 






























 P. edulis 






Coleon T P. caninus 









Kelecom et al., 
1984 



































































(134)  OH 
 
(135) 
Compound Name Synonym 
Isolated from 
Plectranthus 















Horvath et al., 
2004; 















































 R1 R2 R3 R4 
(136)  H H CH3 CH3 
(137) H CHO CH3 CH3 
(138) H H CH2(OH) CH3 
(139) H H CH2OC(O)CH3 CH3 
(140)  OC(O)CH3 H CH2(OH) CH3 






















 R1 R2 R3 
(144)  H H CH2CH(OH)CH3 



















































In compounds 149-165 (Table 9b), an olefinic bond is present at C-5 while oxygenated 
substituents occur at C-11, C-12 and C-14.  With the exception of compound 157, 
compounds 153-165 have either one or both of the isopropyl methyl groups at C-15, 
being oxidized to an acetyl and/or alcohol function.  Compounds 152 and 159 have a 
hydroxy and acetoxy group present at C-3 respectively while compounds 160 and 161 
have an acetyl group at C-2.  Abietanes 163 and 164 have a formyloxy (-OCHO) group at 
C-19 while the isopropyl group at C-13 has been replaced by a linear, 3-carbon side-
chain containing either a double bond or alcohol in compounds 162-164.   
 
Table 9b: Coleon-type abietanes with an olefinic bond at ∆5 isolated from Plectranthus 
and Coleus species 
Compound Name Synonym 
Isolated from 
Plectranthus (P) 

















Wellsow et al., 2006; 
Gaspar-Marques et 
al., 2006;  
Gaspar-Marques et 
al., 2002; 
Cerqueira et al., 
2004; 
Miyase et al., 1977a; 
Yoshizaki et al., 
1979; 
Matloubi-Moghadam 
et al., 1987; 
Kunzle et al., 1987; 
















Coleon U 11 
acetate 





Coleon S P. caninus 
Arihara et al., 1977: 
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Compound Name Synonym 
Isolated from 
Plectranthus (P) 










P. edulis;  
C. forskohlii 
Ruedi et al.,1971; 
Grob et al., 1978; 
Schmid et al., 1982; 
Kunzle et al., 1987; 
Yanwen et al., 2007; 









Grob et al., 1978; 









Grob et al., 1978; 
Miyase et al., 1977a, 























































































 R1 R2 R3 
(149) H H H 
(150) H H C(O)CH3 
(151) H C(O)CH3 H 
(152) OH H H 
 
 R1 R2 R3 R4 
(153) H H CH2OH CH3 
(154) H H CH2OC(O)CH3 CH3 
(155) H H CH2OC(O)CH3 CH2OH 
(156) H H CH2OC(O)CH3 CH2OC(O)CH3 
(157) H C(O)CH3 CH3 CH3 
(158) H C(O)CH3 CH2OC(O)CH3 CH3 
(159) OC(O)CH3 H CH2(OH) CH3 
 
 
Compound Name Synonym 
Isolated from 
Plectranthus (P) 





























































 R1 R2 
(162) H CH2CH(OH)CH3 
(163) OCH(O) CH2CH=CH2 

























  (165)  
 
 
Compounds 166 and 167 (Table 9c) have double bonds within rings A and B.  In 
compound 166, the double bonds are located at C-1(10) and ∆6 respectively while the 
methyl group is no longer at C-10 but at C-5.  In 167 the double bonds occur at ∆3 and ∆5 
and the methyl group at C-19 has migrated from C-4 to C-3.   The linear, 3-carbon side-
chain in this compound has been oxidized to an alcohol.  In compound 166, the 









Table 9c: Coleon-type abietanes with double bonds within ring A and B isolated from 
Plectranthus species 
























Plectrinone A P. barbatus 






















































Eight compounds 168-174 (table 10) do not resemble the abietanes 27-167 as they 
contain carbocyclic and heterocyclic rings which are fused differently from the other 
abietanes.  Compounds 168 to 171 contain a highly conjugated system with ring A being 
aromatic and ring B resembling the hydroxybenzoquinone system.  An oxidised furan 
ring also forms a part of structures 168 to 171.  In compound 172 rings A and B are 
linked by a carbon-to-carbon bond.  Ring A resembles that of the normal ring A in 
abietanes, with methyl groups at C-4 and C-6 and a ketone at C-5, and ring B has the 




has been expanded by an extra oxygen atom forming a seven membered ring with 
carbonyl groups flanking the oxygen at either side.  Compound 174 has four rings fused 
together including an aromatic and lactone ring.  Both compounds 173 and 174 have 
highly conjugated systems.   
 















P. aff puberulentus 














P. puberulentus;  
P. edulis 
Wellsow et al., 
2006; 






 P. edulis 
Kunzle et al., 
1987 
172 




C. xanthanthus Mei et al., 2002 
173 
*Too complex to name 
systematically Sanguinon A P. sanguineus 
Matloubi-
Moghadam et al., 
1987 
174 
*Too complex to name 
systematically Edulon A P. edulis 
Buchbauer et al., 
1978; 




































































 R1 R2 R3 
(168) H OH CH3 





























2.5 Biological activity of the phytochemical constituents of Plectranthus 
 
The antibacterial and antifungal activities of abietanes isolated from Plectranthus species 
are listed in table 11.  Of the one-hundred and fifty abietanes isolated from Plectranthus 
and Coleus species, only twenty are reported as having showed antimicrobial activity.  
These twenty abietanes were isolated from eight Plectranthus species with horminone 
(28), 7α-acetoxy-6β-hydroxyroyleanone (36), 7α,12-dihydroxy-17(15→16)-abeoabieta-
8,12,16-triene-11,14-dione (55), 16-acetoxy-7α,12-dihydroxy-8,12-abietadiene-11,14-
dione (54) and Coleon U (149) being isolated from more than one species. 
 
Of all the abietanes isolated from Plectranthus and Coleus species the highest 
antibacterial and antifungal activities were shown by the royleanone and coleon type 
compounds.  These were compounds 28, 36, 38 (7α-formyloxy-6β-hydroxyroyleanone), 
44 (coleon U quinone) and 149.  All these compounds are structurally related and have 
the same basic skeleton with different functional groups located in the molecules.  
However, coleon U has an aromatic ring and the others have a hydroxyquinoid ring C. 
 
Bacillus subtilis and Staphylococcus aureus were the most commonly tested bacterial 
strains while the anti-fungal pathogens tested were Cladosporium cucumerinum, 
Rhizoctonia solani, Sclerotinia sclerotiorum, Pythium ultimum and Candida albicans. 
 
Acetone was the most frequently used solvent for extraction, while dichloromethane, 
chloroform and ethyl acetate were reportedly used only once for the extraction of 
abietanes from the plant material.   
 
Of the eight antimicrobial studies carried out on abietanes, two were done on the roots 
only and two on the entire plant.  The rest of the studies were carried out on the aerial 
parts of the plant and the leaves (aerial parts in many instances mean leaves and flowers). 
Comparative studies need to be done on the different plant parts, to ascertain where the 




The majority of the abietanes isolated remain untested against microbes (bacteria and 
fungi) and there is thus a need to carry out antimicrobial assays on the remainder of the 
abietanes. 
 
It was found that the coleon-type compound (where ring C is aromatic) are more active 
than royleanone-type compounds (where ring C has a 12-hydroxy-p-benzoquinone 
moeity) (Gaspar-Marques et al., 2006; Wellsow et al., 2006). 
 
It has been observed that the oxidation pattern at the C-6 and C-7 positions in compounds 
having a royleanone-type structure plays a role in the antibacterial activity of the 
compound with compounds where C-7 is oxidised being more active than those oxidised 
at C-6 or not oxidised at all (Teixeira et al., 1997; Gaspar-Marques et al., 2006).  Another 
important observation is that the presence of an isopropyl group at C-13 in royleanone-
type compounds results in better activity than those compounds having an oxidised 
isopropyl group or allylic group at the same position (Gaspar-Marques et al., 2006; 
Batista et al., 1995; Batista et al., 1994).   
 














 (168), (169) B. subtilis 
Wellsow et 
al., 2006 
P. ecklonii ethyl acetate
w










 (109), (132) 
B. subtilis, S. aureus, 
Streptomyces scabies,  
P. aeruginosa,  
Pseudomonas 
syringae, Erwinia 
carotovora,   
*Cladosporium 
cucumerinum 
Dellar et al., 
1996 



































 (27), (28), (32),  
(33), (36), (43), 
(149)  
Six strains of 
methicillin resistant 
S. aureus, two strains 
of vancomycin-















*Pythium  ultimum, 
*unknown Candida 
species 











(28), (54), (55), 
(64) 
Six strains of 
methicillin resistant 
S. aureus, two strains 
of vancomycin-















































* denotes anti-fungal pathogens  
 
x 
Laing et al. (2006) reported the isolation of 7α-acetoxy-6-hydroxyroyleanone and 7α,6-dihydroxyroyleanone 
without including the stereochemistry in the name.  It is thus assumed that these compounds are 7α-acetoxy-6β-
hydroxyroyleanone (36) and 7α,6β-dihydroxyroyleanone (33), respectively 
Key: lv: leaves, rt: roots, s: stems, a: aerial parts, w: whole plant, f: flowers  
 
Three abietanes have also been found in Salvia species where antimicrobial studies were 
carried out (Table 12).  All three of these abietanes have a royleanone-type structure. 
 
Compounds 28 (horminone) and 31 (7α-acetoxyroyleanone) exhibited similar and in 
some cases stronger antibacterial activity to commonly used antibiotics such as 
cefoperazone, amicain, kanamycin and vancomycin (Ulubelen et al., 2001; 2003). 
 
Table 12: Antibacterial and antifungal activity of abietanes isolated from Salvia species 
Plant species Compound Activity Reference 
Salvia sclarea (40) S. aureus, *C. albicans 








S. aureus, S. epidermis, B. 
subtilis, E. faecalis Kolak et al., 
2001; 
Ulubelen et al., 
2001; 2003 (31) 
S. aureus, S. epidermis, B. 
subtilis 
* denotes anti-fungal pathogens   
 
 
Table 13 lists twenty-seven abietanes with antioxidant, anticancer, antifeedant and other 
activity which have been isolated from thirteen Plectranthus species and two Coleus 
species.   
 
Compounds 36 (7α-acetoxy-6β-hydroxyroyleanone), 123 and 124 commonly known as 




anticancer (Cerqueira et al., 2004; Nyila et al., 2009; Gaspar-Marques et al., 2002) and 
antimalarial activity (van Zyl et al., 2008).  Compound 124 also has antioxidant activity 
(Narukawa et al., 2001).  Compound 36 has a royleanone-type structure while the other 
two compounds (123-124) have a vinylogous quinone-type structure.  In the three studies 
that were done on coleon-type and royleanone-type compounds (Mei et al., 2002; 
Cerqueira et al., 2004; Gaspar-Marques et al., 2002), it was found that the coleon-type 
compounds were more effective as anticancer agents than the royleanone-type 
compounds.  
 
When Kabouche et al. (2007) tested the antioxidant activity of royleanone and coleon-
type compounds, they found that the presence of a carbonyl group at C-7 led to higher 
activity as apposed to compounds having no substituent at this position or having a 
substituent other than a carbonyl at C-7.  When the hydroxyl group at C-12 is replaced by 
a methoxy group as in 176, the activity is increased as well (Kabouche et al., 2007).  In 
studies where coleon (compounds where ring C is aromatic) and royleanone-type (where 
ring C has a 12-hydroxy-p-benzoquinone moeity) compounds were isolated, the coleon-
type compounds proved to be more active than the royleanone-type compounds 
(Kabouche et al., 2007; Cerqueira et al., 2004; Mei et al., 2002; Gaspar-Marques et al., 
2002; Narukawa et al., 2001).  However there has been one instance were a royleanone-
type diterpene (Coleon U quinone (44)) showed potent antifeedant activity whereas the 
coleon-type diterpene (coleon U (149)) displayed no activity as an antifeedant (Wellsow 
















The leaves seem to be the most frequently used plant part.  There has been three instances 
where compounds from the entire plant has been tested but only one report on abietanes 
being isolated from the roots of  Plectranthus species.  
 
In ten of the eleven studies on Plectranthus species, polar solvents (ethyl acetate, 
dichloromethane, acetone, ether and water) were used for extraction with there being just 
one report of hexane and dichloromethane being used as a solvent for extraction.  This is 
probably because abietanes are best isolated with a polar solvent medium as many of the 
abietanes are highly functionalised with carbonyl and hydroxyl groups. 
 











 (in vivo and in vitro) 
Xiu et al., 2008 
taken orally or 
applied topically 
inhibits growth and 
proliferation of tumors 
Yanwen et al., 
2007 





cytotoxic against K562 
human leukemia cells 
Mei et al., 2002 
P. ecklonii ethyl acetate
w
  (123), (124) 
active against vero cell 
line 






  (149)  
promising anti-cancer 
drug 














against the expression of 
CD69 by T- and B-








(33), (35), (36), 
(47), (149) 
anti-tumor activity 
(breast, lung, renal, 
melanoma and CNS) 
Gaspar-Marques 
et al., 2002 

















antioxidant activity  







 (168), (169) 
antifeedent activity 
against S. littoralis 




   (90) 
insect antifeedent 
activity against S. 
gramium and  
P. gossypiella 





(44) antifeedent activity 
against S. littoralis 
Wellsow et al., 
2006 
P. puberulentus (170) 
Antimalarial activity  
P. ecklonii dichloromethane
lv

































  (169) 
antisecretory and 
antiulcer activities  
Schultz et al., 
2007 
P. ecklonii ethyl acetate
w
  (123), (124) 
inhibits tyrosinase 
activity 
Nyila et al., 2009 
P. grandis hexane
lv
 (70), (87) 
gastroprotective 
properties, in mice 






against Herpes virus ie. 
Herpes simplex type II 
Batista et al., 
1995 
NB. Coleus species are also included in this table because of the uncertain relationship to the Plectranthus species   





Table 14 contains six abietanes isolated from five known Salvia species, one unknown 
Salvia species and one Lepechinia species.  These compounds have been shown to 
possess anticancer, antioxidant or cardiovascular activity with compounds 27 
(royleanone) having antitumor and antioxidant activity and 28 (horminone) having 
antitumor, anticancer and antioxidant activity.   
 
The royleanone-type abietanes (27, 28, 32 and 44) have shown to exhibit anticancer, 
antioxidant and cardiovascular activity while the coleon-type compounds (134 and 146) 
have proved to be active only against cancer cell lines.   
 
Table 14: Pharmacological activity of abietanes isolated from other plant species 
Plant species Compound Activity Reference 
Salvia pachyphylla (146) 
Active against human 
cancer cell lines 
Guerrero et al., 
2006 
Salvia hypargeia (134) 
Active against ovarian 
cancer cell line (A2780) 





Topcu and Goren, 
2007 
Lepechinia bullata (28), (43) Anticancer 





Kolak et al., 2001; 





Kolak et al., 2001; 






Kabouche et al., 
2007 
* unknown species 
 
The distinguishing feature of an abietanoid structure which determines the activity of the 
compound, is the oxidation pattern within ring B and ring C.  It has been observed that 
the oxidation patterns at C-6, C-7 and C-12 influence the activity of the abietanoid.  
Compounds having a coleon-type structure (where ring C is aromatic) have proven to be 
more active than royleanone-type compounds (where ring C has a 12-hydroxy-p-




Two compounds, 7α-acetoxy-6β-hydroxyroyleanone (36) and coleon U (149) have 
shown to have the widest range of biological activity with compound 149 always being 
more active than compound 36 and occasionally having even stronger activity than the 
well known drugs used as controls.  
 
Although much has been done on testing the abietanes for biological activity, there are 
still many abietanes which have not been tested for any biological or pharmacological 
activity.  These assays will prove useful in determining the structure-activity relationships 
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Chapter 3    Extractives from Plectranthus hadiensis 
3.1 Introduction 
 
Plectranthus hadiensis is commonly known as the ‘hairy spurflower’ or ‘imbozisa’ by the 
Zulus.  This plant is a shrubby perennial which grows to a height of 1.5 metres and 
flowers between March and June every year, peaking in May (van Jaarsveld, 2006). The 
flower blossoms are purple in colour (figure 15) and are pleasantly aromatic.  
  
 
Figure 15: Plectranthus hadiensis in bloom (picture courtesy of Prof. N. Crouch) 
 
P. hadiensis favours dry conditions for growth and can be found growing between the 
Kwa-Zulu Natal coastline and Gauteng, South Africa.  The cuttings of this plant are used 
for propogation purposes (van Jaarsveld, 2006).     
   
Ethnobotanically, P. hadiensis was reported by Lukhoba et al. (2006) as having been 
known to treat certain skin conditions, diarrhoea in South India and Sri Lanka (Mehrotra 
et al., 1989) respiratory conditions and inflammation (loc cit Sivarajan and Balachandran, 
1986; Neuwinger, 2000; Hutchings et al, 1996).  However the literature cited in Lukhoba 




There have been only four biological studies on Plectranthus hadiensis where the 
antiplasmodial, insect-antifeedant, antifungal, antiradical and antibacterial properties of 
this plant extract and the isolated compounds were evaluated for activity (van Zyl et al., 
2008; Laing et al., 2006; Mothana et al., 2008; Wellsow et al., 2006).  The acetone 
extract of this plant was found to be inactive as an insect-antifeedant (Wellsow et al., 
2006).  The hexane extract showed good activity against Sclerotinia sclerotiorum, 
Rhizoctonia solani and an unknown Candida species while the dichloromethane extract 
showed moderate activity against bacterial strains, B. subtilis and X. campestris and the 
fungal microorganism, Sclerotinia sclerotiorum as well as an unknown Candida species 
(Laing et al., 2006).   
 
Three royleanones 33, 36 and 38 were isolated previously from the dichloromethane 
extract of the aerial parts of P. hadienis (van Zyl et al., 2008) and the isomers of 33 and 
36, 34 and 37 respectively, were isolated from the ethanol extract of Coleus zeylanicus (a 
synonym for P. hadiensis) (Mehrotra et al., 1989).  Compounds 33 and 36 exhibited 
anticancer activity against breast, lung, renal, melanoma and central nervous system cell 
lines (MCF-7, NCI-H460, TK-10, UACC-62 and SF-268, respectively) with both 
compounds proving to be less potent than the positive control, Cyclosporin A (Cerqueira 
et al., 2004; Gaspar-Marques et al., 2002).  These three compounds (33, 36 and 38) have 
also proven to be active against six strains of methicillin resistant Staphylococcus aureus, 
two strains of vancomycin-resistant Enterococcus faecalis, Bacillus subtilis, Vibrio 
cholera and Xanthomonas campestris (Laing et al., 2006; Teixera et al., 1997; Gaspar-
Marques et al., 2006).  Compounds 36 and 38 (van Zyl et al., 2008) exhibited 
antimalarial activity with 38 displaying synergistic properties when combined with 
quinine (Tables 11 and 13 on pages 72 and 76, respectively).  There were no reports of 






























The purpose of this study was to perform phytochemical analyses on the stem and leaf 
material of Plectranthus hadiensis in the hope of isolating abietane diterpenes to test 
against Enterococcus faecalis and Pseudomonas aeruginosa bacterial microorganisms 
and breast (MCF-7), renal (TK-10) and melanoma (UACC-62) cancer cell lines.  Since 
there has been no reports of compounds 34 and 37 possessing any biological activity, it 
was decided to evaluate these compounds for antibacterial and anticancer activity.  We 
hope to compare our activity against E. faecalis with that reported in the literature and to 
report for the first time the antibacterial activity.  We also hope to compare the anticancer 
activity of known compounds from P. hadiensis with that in the literature and report on 
the anticancer activity of any new compounds isolated from P. hadiensis.   
 
Research has been conducted previously on the aerial parts, roots and leaves (Mothana et 
al., 2008; Laing et al., 2006), but there has been no phytochemical reports on the stem 
material.  Since the aerial parts, roots and leaves of P. hadiensis were found to possess 
antiradical, antibacterial and antifungal activity (Mothana et al., 2008; Laing et al., 2006), 










3.2 Foreword to Experimental 
 
Nuclear Magnetic Resonance (NMR) Spectroscopy 




C, DEPT, HETCOR, COSY, NOESY, HSQC and HMBC) were 
recorded on either the Bruker 400MHz or 600MHz NMR spectrometer at the University 
of Kwa-Zulu Natal, Westville campus.  TMS was used as an internal standard and 
chemical shifts were given as δ (ppm), and the coupling constants (J) were reported in 
Hz.  In the case of the 400 MHz NMR instrument, the operating frequency for the 
1
H 
NMR spectra was 400 MHz and for the 
13
C NMR spectra was 100 MHz and in the 600 









Column chromatography was carried out with silica gel (Merck 60, 0.040-0.063 mm) as 
the stationary phase. All crude extracts were separated on 4.5 cm diameter columns with 
step gradients of binary solvent systems and 100 ml fractions were collected with ten 
fractions for each step of the gradient.  Elution of the columns was initiated with the least 
polar organic solvent, hexane, followed by dichloromethane, ethyl acetate and methanol 
in a stepwise gradient until the column had been eluted with 100% methanol.  Thin layer 
chromatography (TLC) was done concurrently with column chromatography in order to 
monitor the elution of compounds.  Merck 20 x 20 cm silica gel 60 F254 aluminium plates 
were used and visualized with anisaldehyde spray reagent [anisaldehyde: concentrated 
hydrochloric acid: aqueous methanol (1:2:97)]  by spraying the plates and then heating.  
UV light (254 and 366 nm) was also used to detect compounds with conjugated double 
bonds.   
 
Similar fractions were combined and purified on columns of varying diameter (1.5-2.5 
cm) depending on the amount of the material to be purified and are referred to as 2cm 




a few cases (specifically stated in the experimental) all purifications were carried out on 
2cm diameter columns collecting 50 ml fractions.  Where 3cm and 1cm columns were 
used, 100 ml fractions and 10 ml fractions were collected respectively.  Any deviations to 
these conditions are mentioned specifically in the experimental. 
 
 
Infrared Spectroscopy (IR Spectroscopy) 
Infrared spectra were recorded on a PerkinElmer
TM
 Spectrum 100.  The sample was 
dissolved in either dichloromethane or methanol before being loaded onto the surface of 
potassium bromide discs. 
 
 
Ultraviolet Absorption Spectroscopy (UV) 
Ultraviolet absorption spectra were recorded with a PerkinElmer
TM
 Lambda 35 UV/VIS 
spectrophotometer.  Samples were dissolved in either dichloromethane or methanol and 




Optical rotations were performed with a PerkinElmer
TM
, Model 341 Polarimeter.  The 
samples were dissolved in dichloromethane or methanol and were measured at room 
temperature.  Concentrations were calculated in g/100mL.   
 
 
Gas Chromatography-Mass Spectrometry (GC-MS) 
The mass spectra were registered on an Agilent MS 5973 instrument which was coupled 
to an Agilent GC 6890 instrument equipped with a DB-5MS (30m x 0.25 id, 0.25 µm 
stationary phase) column.  Helium (at 0.7ml/min) was used as the carrier gas. Optimal 
results required that the oven temperature be maintained at 200
o
C for one minute 
followed by 5
o






C was attained.  This temperature was then held constant for a further eight minutes.  
The MS was operated in the EI mode at 70eV, in m/z range 100-500.   
 
 
Liquid Chromatography-Mass Spectrometry (LC-MS) 
The mass spectra were recorded on an Agilent 1100 Series LC/MSD Trap instrument 
operating in the negative ion mode and equipped with an electrospray interface. Helium 
(at 9ml/min) was used as the carrier gas.  Separation was achieved using a mobile phase 
consisting of 95:5 acetonitrile:water containing 0.1% TFA at a flow rate of 0.3ml/min. 
The mass spectrometer was run in a partial scan mode range m/z 100-500.  
 
 
Melting Point Determination 
Melting points were determined on a Kofler micro hotstage melting point apparatus and 
are uncorrected.  Compounds for melting point determination were recrystallised from 
dichloromethane or methanol before determining the melting point. 
 
 
General extraction procedure 
Plants were air dried, the stems milled and the leaves ground.  Using a soxhlet, the plant 
material was extracted successively using hexane, dichloromethane, ethyl acetate and 
methanol.  The plant material was extracted for forty-eight hours each with each of the 
four solvents and the extracts concentrated using a Buchi rotary evaporator.  Crude 
extracts were stored in the fridge to prevent degradation of compounds and fungal 
contamination until they were ready to be purified further. 
 
3.3 Experimental 
Leaf and stem materials of Plectranthus hadiensis were collected in May 2007 in Kloof, 
Kwa-Zulu Natal by Professor Neil Crouch.  A voucher specimen (N. Crouch 1126, NH) 





The leaves (184.63g) were air-dried, shredded in a domestic blender and extracted using 
the general extraction procedure above.  Concentration of the extracts resulted in masses 
of 9.42 g, 1.72 g, 5.67 g and 17.86 g respectively for hexane, dichloromethane, ethyl 
acetate and methanol.  The stems (511.29g) were milled and extracted as above, yielding 
extracts of 3.96 g, 1.39 g, 0.98 g and 9.32 g from hexane through to methanol 
respectively. 
 
Separation of the leaf extract 
The hexane extract (9.42g) was eluted with a step gradient of hexane:dichloromethane 
(3:2; 1:1; 2:3; 1:4; 0:1), dichloromethane:ethyl acetate (4:1; 3:2; 1:1; 2:3; 1:4; 0:1) and 
ethyl acetate:methanol (4:1; 1:1; 0:1).  TLC and NMR analysis of the crude fractions 
indicated that fractions 20-22, 23-40, 61-66 and 67-71, each contained compounds that 
showed characteristic 
1
H NMR resonances for either abietane diterpenes or sterols and 
were chosen to be purified further. 
 
Fractions 20-22 was purified with 80% dichloromethane in hexane on a 2cm diameter 
column collecting 20 ml fractions, where fractions 11-12 contained stigmasterol (V).  
This compound was identified by its 
1
H NMR spectrum and by comparison with an 
authentic sample.   
 
Fractions 23-40, eluted with 60% dichloromethane in hexane and needed no further 
purification (compound I).   
 
Fractions 61-66 was first purified with ethyl acetate:dichloromethane (20:80) on a 3cm 
column collecting 50 ml fractions.  Fractions 8-15 of this column was further purified 
with ethyl acetate:hexane (60:40) on a 2cm column collecting 20 ml fractions where the 





Fraction 67-71 was purified with 20% ethyl acetate in dichloromethane on a 2 cm 
diameter column collecting 20 ml fractions where fraction 25-42 contained the pure 
compound III. 
 
The dichloromethane, ethyl acetate and methanol extracts were chromatographed with 
step gradients from hexane through to methanol but did not result in the isolation of any 
compounds that could be identified.   
  
Separation of the stem extract 
The hexane extract (3.96g) was eluted with dichloromethane:hexane (1:4; 2:3; 3:2; 4:1; 
1:0), ethyl acetate:dichloromethane (1:4; 2:3; 3:2; 4:1; 1:0) and ethyl acetate:methanol 
(4:1; 1:1; 0:1).  Two fractions of interest were obtained; fractions 13-16 and 17-23. 
 
Fraction 13-16 was purified further on a 2 cm diameter column with 20% 
dichloromethane in hexane collecting 20 ml fractions.    Fraction 18-20 of this column 
was further purified with 20% ethyl acetate in hexane as above where fraction 6 
contained more stigmasterol (V).  
 
Fractions 17-23 of the crude column was purified on a 3cm column with 
dichloromethane:hexane (3:7 for fractions 1-20 and 7:3 for fractions 21-40), where 
fractions 27-30 was purified with 30% ethyl acetate in hexane and then fraction 6 of this 
column was purified with 20% ethyl acetate in hexane where fraction 10-11 resulted in 
the pure compound II and fraction 12 contained lupeol (VI).  The purifications were done 
in 2cm columns, collecting 20 ml fractions.  Lupeol was identified from its 
1
H NMR 
spectrum and in comparison with an authentic sample contained in the laboratory.   
 
The dichloromethane extract (1.39g) was eluted with dichloromethane:hexane (2:3; 3:2; 
4:1; 1:0), ethyl acetate:dichloromethane (1:4; 2:3; 3:2; 4:1; 1:0) and ethyl 
acetate:methanol (4:1; 1:1; 0:1) on a 3 cm column collecting 100 ml fractions at each 
stage.  Fraction 53-60 was purified with ethyl acetate:dichloromethane (1:1) on a 3cm 




The ethyl acetate extract (0.98g) was eluted with dichloromethane:hexane (1:4; 2:3; 3:2; 
4:1; 1:0), ethyl acetate:dichloromethane (1:4; 2:3; 3:2; 4:1; 1:0) and ethyl acetate: 
methanol (4:1; 1:1; 0:1). The 
1
H NMR spectrum of the combined fractions 27-31 
indicated the presence of stigmasterol (V).  
 
The methanol extract was chromatographed with a step gradient of 10%-40% methanol in 
dichloromethane but no compounds were isolated for which structural elucidation could 
be carried out.  NMR spectroscopy of the crude extracts showed mainly the presence of 
sugars. 
 
3.4  Results and Discussion of the compounds isolated 
We have isolated the two previously found royleanone compounds (7β-acetoxy-6β-
hydroxyroyleoanone (I or compound 37 as listed in table 6a) and 6β,7β-
dihydroxyroyleaonone (II or compound 34 as listed in table 6a) from the hexane extract 
of the leaves and the hexane extract of  the stem of P. hadiensis, respectively.   This was 
the first occurrence of compound III (ent-pimara-8(14),15-diene-3β,11α-diol) in 
Plectranthus, which was isolated from the hexane extract of the leaves.  Compound III 
was found previously in Erythroxylum cuneatum which belongs to the Erythroxylaceae 
family (Ansell, 1989).  Further to this, three triterpenoids (IV-VI) were isolated from the 
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Compound I is a yellow crystalline compound soluble in dichloromethane and methanol 
with a melting point of 197 °C and an optical rotation of [α]
20
D +29° (c 0.0052g/100ml, 
CHCl3) [Mehrotra et al., 1989, optical rotation = +23°].  The mass spectrum showed a 
molecular ion peak at m/z 390 corresponding to a molecular formula of C22H30O6 and 
fragment ion peaks at m/z 372 (M
+
 - H2O) and 357 (M
+
 - H2O - CH3).  The IR spectrum 
showed carbonyl stretching bands at 1734 cm
-1
, O-H stretching bands at 3377 cm
-1
, 
alkene stretching bands at 1641 cm
-1
 and C-H bending vibrations of the isopropyl group 
at 1375 cm
-1
.  The UV spectrum showed a maximum absorbance at a wavelength of 




H NMR spectrum of compound I showed deshielded methine resonances at δH 5.64 
(H-7) and δΗ 4.30 (H-6) as well as a methine resonance of an isopropyl group (H-15) at 
δΗ 3.14.  One of the protons of the methylene group at C-1 resonating at δΗ 2.62 could 
also be clearly seen as well as three methyl group resonances at δH 0.92 (3H-18ax), 1.62 
(3H-20eq) and 2.02 (OC(O)CH3).  Three other methyl groups were also present in the 
1
H 
NMR spectrum, but were not clearly distinguishingable as they overlapped with each 
other.  These were the methyl resonances at positions 16, 17 and 19 which occurred at 







C NMR spectrum showed the presence of twenty-two carbon resonances of which 
three were attributed to carbonyl groups (C-11, 14 and the acetyl carbonyl), four to 
substituted olefinic carbon atoms (C-8, 9, 12 and 13) (indicating two double bonds in the 
structure), two to quaternary carbon resonances (C-4 and 10), four to methine (C-5,6,7 
and 15), three to methylene (C-1, 2 and 3) and six to methyl (C-16, 17, 18, 19, 20 and the 
acetyl methyl carbon).  The methine and methyl resonances were identified using both 
the DEPT and the HSQC spectra.  It must be noted that the C-18 methyl carbon 
resonance is more deshielded than the methine carbon resonance of C-15.   This can be 
be distinguished clearly in the HSQC spectrum with δC 24.17 (C-15) showing a 
correlation to the methine proton resonance at δH 3.14 (H-15) and δC 33.68 (C-18) 
showing a correlation to the methyl proton resonance at δH 0.92 (3H-18ax). 
 
The resonances at δH 4.30 and δH 5.64 were both coupled in the COSY spectrum.  Since 
both these resonances were deshielded, both these groups had an oxygen substituent 
attached to them.  The H-7 resonance showed HMBC correlations to six carbon 
resonances (δC 49.75, 67.05, 137.08, 149.90, 169.61 and 185.76), two of which are 
aliphatic, two are olefinic and two are carbonyl.  The aliphatic carbon resonance at δC 
49.75 also shows HMBC correlations to three methyl resonances and was therefore 
attributed to C-5, with the three methyl resonances at δH 0.92, δH 1.23 and δH 1.62 being 
3H-18, 3H-19 and 3H-20.  Both the olefinic carbon resonances which showed HMBC 
correlations to H-7 were fully substituted and were therefore attributed to C-8 (δC 137.08) 
and C-9 (δC 149.90), which could be distinguished because the resonance at δC 137.08 
showed an additional HMBC correlation to H-6.  Of the two carbonyl resonances which 
showed HMBC correlations to H-7, one was assigned to the acetyl carbonyl at δC 169.61 
as this is coupled to the acetyl methyl group at δH 2.02 in the HMBC spectrum.  The 
other carbonyl group at δC 185.76 was assigned to C-14. 
 
The C-14 carbonyl group showed HMBC correlations to the methine proton resonance at 
δH 3.14 (H-15).  This resonance was the methine resonance of the isopropyl group and 




resonance showed HMBC correlations to the other two olefinic resonances at δC 150.90 
and δC 124.67 as well as the carbonyl resonance at δC 185.76.  These resonances were 
therefore assigned to C-12 (δC 150.9), C-13 (δC 124.67) and C-14 (δC 185.76).  The C-12 
and C-13 resonances were distinguished based on chemical shift as the more deshielded 
resonance of C-12 at δC 150.90 was assigned to the olefinic carbon where the hydroxyl 
group is situated.  The hydroxyl group proton resonance at δH 7.21 showed HMBC 
correlations to both C-12 and C-13 and to the other carbonyl resonance at δC 183.28, 
which was then assigned to C-11. 
 
One of the 2H-1 resonances was present at δH 2.62 and the other overlapped with the 3H-
16 and 3H-17 methyl resonances at δH 1.18, determined by the HSQC correlation with C-
1.  The other two non equivalent methylene resonances at C-2 and C-3 were assigned due 
to the C-3 carbon resonance at δC 42.27 showing a HMBC correlation with the two 
methyl resonances at δH 1.23 (3H-19ax) and δH 0.92 (3H-18eq).  The C-2 carbon 
resonance was assigned to the remaining methylene resonance.  The resonance at δH 1.62 
was assigned to 3H-20 since C-5 showed correlations to all three methyl resonances, 3H-
18eq, 3H-19ax and 3H-20ax.  
 
Of the remaining two quaternary resonances at δC 33.54 and δC 38.63, the resonance at δC 
38.63 was assigned to C-4 based on a HMBC correlation with H-6.   
 
The stereochemistry of H-5, H-6 and H-7 were ascertained from coupling constants and 
using a molecular model to determine their dihedral angles and assuming the H-5 proton 
to be axial.  Since the H-5, H-6 and H-7 proton resonances were all slightly broadened 
singlets, we were looking for a model where the dihedral angles between H-5 and H-6, 
and H-6 and H-7 were close to 90°.  This was possible if the H-5 proton was axial 
(alpha), H-6 was equatorial (alpha) and H-7 was axial (alpha).  This indicates that the 
hydroxyl group at C-6 is axial (beta) and that the acetoxy group at C-7 is equatorial (beta) 




1,3-diaxial interaction between 3H-20 and the 6β-hydroxy group results in a 






























Figure 16: Chair conformation of compound I showing the relationship between H-
5, H-6 and H-7 
 
There have been two reports of compound I being isolated previously (Mehrotra et al., 
1989; Rasikari, 2007).  The NMR data compares well with literature (Rasikari, 2007), 
however the C-4 and C-10 resonances are switched around, but we have assigned C-4 
based on an HMBC correlation with H-6 and are confident in our assignment.  With 
regard to the stereochemistry of the molecule, in Rasikari (2007) it is important to point 
out that the stereochemistry in the name of the compound does not correspond with the 
structure.  We think that the compound was incorrectly named as 7α-acetoxy instead of 
7β-acetoxy as a coupling constant of 3.5 Hz is used as a basis for this assignment.   
Mehrotra et al. (1989) is also used as a comparison in the identification in Rasikari et al. 
(2007).  However, Mehrotra et al. (1989) observed a JH-6, H-7 of 3.5 Hz, close enough to 
that observed by Rasikari (2007) of JH-6, H-7 of 2.0 Hz, and concluded a 6β-axial, 7β-
equatorial configuration.  The structure of the molecule in Rasikari (2007) is however 




H NMR data also compares well to that in Mehrotra et al. (1989), the carbon 
resonances of C-6, 13, 15-17, 19 and 20 all differ by 1-3 ppm and the carbon resonance 




resonance at δC 185.76 of C-14 is also different to that of 179.00 and that of the acetyl 
carbon at δC 169.61 is 3ppm higher than the acetyl carbon at 166.00.  The C-2 carbon 
resonance in compound I is also 5ppm lower than that cited in Mehrotra et al. (1989).  
 
Although Hensch et al. (1975) report the 7α-axial acetoxy isomer, the coupling constant 
JH-6, H-7 is reported to be 2.0 Hz and we think that this is the 7β-equatorial acetoxy isomer.  
The NMR data is therefore used for comparison.  The NMR data for compound I 
compares well with that in Hensch et al. (1975). 
 
Compound II is a yellow compound soluble in dichloromethane and methanol with a 
melting point of 125 °C  and an optical rotation of [α]
20
D -47° (c 0.0063g/100ml, CHCl3).  
The GC-MS did not show a molecular ion peak at m/z 348 but the LC-MS showed a peak 
at m/z 347 in the negative ion mode which supports the molecular formula of C20H28O5 
with a molecular mass of 348 amu.  The UV spectrum showed a maximum absorbance at 






C NMR data for compound II is similar to that of compound I, with a few 
notable differences.  The H-7 resonance moved upfield from δH 5.64 to δH 4.54.  The 
methyl acetyl resonance at δH 2.02 was also absent and a new one-proton resonance 
appeared as a broad singlet at δH 3.00.  Another broad singlet could now be distinguished 
at δH 1.70.  In the 
13
C NMR spectrum of compound II, the acetyl carbonyl resonance was 
absent as well as the acetyl methyl resonance.  Furthermore, the carbonyl stretching band 
in the IR spectrum was also absent.  All these changes were consistent with the acetyl 
group at C-7 being replaced by a hydroxyl group. 
 
The broad singlet resonance at δH 3.00 was attributed to the hydroxyl group proton at C-7 
because of a COSY correlation to H-7.  This proton resonance did not correlate to any of 
the carbon resonances in the HSQC spectrum.  The resonance at δH 1.70 also did not 
correlate to any of the carbon resonances and was attributed to the hydroxyl group at C-6.  




distinguished from the other resonances that occurred along with it.  The C-9 carbon 
resonance showed a HMBC correlation with H-7 and CH3-20 and the C-8 carbon 
resonance showed a HMBC correlation to the H-7 resonance as well as the H-6 
resonance.  These correlations confirmed the assignments of H-6 and H-7 as well as C-8 
and C-9.  
 
The H-5, H-6 and H-7 resonances had the same slightly broadened singlet profile as that 
of compound I and therefore the same stereochemistry would be prevalent here as well 
with a 6β-ax, 7β-eq-dihydroxy form.  The paramagnetic shift for the 3H-20 resonance is 
also observed in compound II as well as for 3H-19β-ax methyl group which is more 
deshielded at δH 1.62 than that of 3H-18 at δH 1.06. 
 
Compound II was isolated previously from Mehrotra et al. (1989).  Rasikari (2007) and 
Hensch et al. (1975) report the 7α-axial-hydroxy isomer. However, the coupling 
constants of JH-6, H-7 in both Rasikari (2007) and Hensch et al. (1975) are 2.0 Hz and 
therefore we think that these compounds may also be the 7β-equatorial-hydroxy and not 
the 7α-axial-hydroxy isomer.  The NMR data of all three references are thus used for 
comparison.  The 
1
H NMR data compare well, with a consistent 6-7 ppm difference for 
Hensch et al. (1975).  The 
13
C NMR data compared well with that of Rasikari (2007).  No 
13











 (Mehrotra. et al., 
1989) 
(80MHz) 




 (J = 12.72 Hz) 
2.65, dt 














(J = 13.4, 3.5 Hz) 
  





Position Moiety Compound I 
Rasikari, 2007 
(500MHz) 
 (Mehrotra. et al., 
1989) 
(80MHz) 





(J = 12.8 Hz) 
  
1.18 1.24, m   
5 CH 
1.32, s  
(w½ = 3.6 Hz) 
1.35, s   
6 CH 4.30, s 4.33, s 
4.25, dd 
(J = 3.5, 2.0 Hz) 
4.34, m 
-OH    2.46, s 
7 CH 5.64, s 
 5.62, d 
 (J = 3.5 Hz) 
5.70, d 
(J = 2 Hz) 
12 -OH 7.21, s 7.20 7.20, s 7.25, s 
15 CH 3.14, sep 
3.18, hept 
(J = 7.1 Hz) 
3.15, sep 
(J = 7 Hz) 
3.16, m 
(J = 7 Hz) 
16 CH3 1.18, d  
(J = 7.08 Hz) 
1.24, d 
(J = 7.1 Hz) 1.15, d 
(J = 7 Hz) 
1.20, d 
(J = 7 Hz) 
17 CH3  
18 CH3 0.92, s 0.96, s 0.90, s 0.88,s 
19 CH3 1.23, s 1.24, s 1.20, s 1.24, s 
20 CH3 1.62, s 1.63, s 1.60, s 1.62, s 
7-
OCOCH3 










  (Rasikari., 2007) 
(125MHz) 
 (Mehrotra. et al., 1989) 
(20MHz)
 
 (Hensch et al., 1975) 
(60MHz)
 
1 CH2 38.35 38.6 38.50 38.7 
2 CH2 18.97 19.2 24.00 24.2 
3 CH2 42.27 42.5 42.50 42.5 
4 C 38.63 33.9 39.00 38.4 
5 CH 49.75 50.0 49.50 49.9 
6 CH 67.05 67.3 68.00 67.2 
7 CH 68.74 69.0 70.00 68.9 
8 C=C 137.08 137.3 137.50 137.3 
9 C=C 149.90 150.1 150.50 150.1 
10 C 33.54 38.9 34.50 33.6 
11 C=O 183.28 183.5 183.50 185.9 
12 C=C 150.90 151.1 151.00 151.1 
13 C=C 124.67 124.9 126.00 124.8 
14 C=O 185.76 186.0 179.00 183.6 
15 CH 24.17 24.4 23.00 23.8 




Position Moiety Compound I 
 (Rasikari., 2007) 
(125MHz) 
 (Mehrotra. et al., 1989) 
(20MHz) 
 (Hensch et al., 1975) 
(60MHz) 
16 CH3 19.71 19.9 22.00 *19.7 
17 CH3 19.85 20.1 22.50 *19.8 
18 CH3 33.68 33.7 21.00 
#
33.7 
19 CH3 23.82 24.1 20.00 *19.1 
20 CH3 21.51 21.8 23.50 *21.5 
7-
OCOCH3 
 20.95 21.1 20.50 *20.9 
7-
OCOCH3 
 169.61 169.8 166.00 169.9 
* Resonance for each methyl group not specified 





H NMR data for compound II compared with three reference compounds 
(CDCl3, 400MHz) 
Position Moiety Compound II 
Rasikari, 2007 
(500 MHz) 
 (Hensch et al., 1975) 
(60MHz) 




(J = 3.08 Hz) 
2.59, dt 
(J = 10.2, 3.5 Hz) 
2.53, m  
1.17 
1.19, td 
(J = 12.7, 3.6 Hz) 
  
2 CH2 
1.57 1.61, m   
1.85 
1.82, qt 













(w½ = 4.4 Hz) 
1.45, s   
6 
CH 4.48, s 4.45, s 4.39, m 4.50, m 
-OH 1.70, brs    
7 
CH 4.54, s 
4.50, d 
(J = 1.8 Hz) 
4.43, d 
(J = 2 Hz) 
4.50, m 
-OH 3.00, brs    
12 -OH 7.34, s 7.25, s   
15 CH 3.18, sep 
3.17, hept 
(J = 7.1 Hz) 
3.10, m 
(J = 7 Hz) 
3.15, sep 
(J = 7 Hz) 
16 CH3 1.24, d 
(J = 6.92 Hz) 
1.21, d 
(J = 7.1 Hz) 
1.14, d 
(J = 7 Hz) 
1.30, d 
(J = 7 Hz) 17 CH3 
18 CH3 1.06, s 1.04, s 0.99, s 1.05, s 
19 CH3 1.27, s 1.26, s 1.23, s 1.20, s 














1 CH2 38.43 38.8 
2 CH2 19.03 19.3 
3 CH2 42.31 42.6 
4 C 33.75 34.0 
5 CH 49.50 49.8 
6 CH 69.31 69.6 
7 CH 69.13 69.4 
8 C=C 140.94 141.2 
9 C=C 147.54 147.7 
10 C 38.56 38.8 
11 C=O 183.44 183.7 
12 C=C 151.20 151.4 
13 C=C 124.26 124.5 
14 C=O 189.14 189.4 
15 CH 24.02 24.3 
16 CH3 19.86 20.0 
17 CH3 19.80 20.0 
18 CH3 33.52 33.7 
19 CH3 24.27 24.5 
20 CH3 21.62 21.9 
 

























Compound III is a colourless compound soluble in both dichloromethane and methanol 
with a melting point of 89°C and an optical rotation of [α]
20
D -79° (c 0.0082g/100ml, 




molecular formula of C20H32O2 and fragment ion peaks at m/z 286 and 268.  These 
fragment ion peaks are brought about when compound III loses one and two water 
molecules consecutively.  The IR spectrum showed O-H stretching bands at 3396 cm
-1
 
and C-H stretching bands at 2930 cm
-1
.  The UV spectrum showed a maximum 




H NMR spectrum indicated the presence of four tertiary methyl groups with 
resonances at δΗ 1.01, 0.99, 0.78 and 0.75, two double bonds with four olefinic proton 
resonances at δH 5.72, δH 5.20, δH 4.90 and δH 4.88 and two oxygenated methine groups 
with resonances at δΗ 3.26 and δΗ 3.85.  The resonances at δH 5.72 (dd, J = 17.21, 10.57 
Hz), δH 4.90 (dd, J = 10.57, 1.16 Hz) and δH 4.88 (dd, J = 17.21, 1.16 Hz) was typical of 
a vinyl group (H-15, H-16a and H-16b, respectively) (Lyder et al., 1998).  A deshielded 
methine resonance at δΗ 3.25 is typical for compounds with a hydroxyl group at the 3-




C NMR spectrum showed the presence of twenty carbon resonances typical of a 
diterpenoid of which four were olefinic 146.18 (CH=), δC 137.46 (C), 127.64 (CH=) and 
112.69 (CH2) indicating two double bonds, three were quaternary (δC 39.11, 39.05 and 
39.57), four were aliphatic methine carbon groups, five were methylene and four were 
methyl.  
 
The interesting point about this molecule is that the methyl resonance at δH 1.01 showed 
HMBC correlations to the vinylic carbon resonance (C-15), the olefinic resonance at δC 
127.64 (C-14) and a methylene resonance at δC 45.85 (C-12).  Since this methyl group 
was aliphatic, indicated by its chemical shift, the two double bonds could not be 
conjugated and had to be separated by an aliphatic carbon.  Ring C and its constituents 
could then be constructed as in figure 17 and the methyl proton resonance was assigned 







The equatorial methyl group at C-4, usually resonates at approximately δΗ 28 and the 
axial methyl group at this position resonates at approximately δΗ 15 (Ansell, 1989; Kang 
et al., 2005; Meragelman et al., 2003).  This was used to assign the resonances at 
δΗ 28.43 and δΗ 15.59 to 3H-18βax and 3H-19αeq, respectively.  In the HMBC spectrum, 
3H-18βax and 3H-19αeq showed correlations to C-3 as well as a quartenary carbon at δC 
39.11 (C-4) and an aliphatic methine at δC 53.99 (C-5).  The C-5 resonance in turn 
showed a HMBC correlation to another methyl group at δH 0.75 which could only be 
assigned to 3H-20.  This 3H-20 resonance was then used to assign C-10 and C-9 at δC 
39.05 and δC 59.83 respectively because of HMBC correlations to them. 
 
The tertiary carbon atom, C-13 could be assigned to δC 39.57 because of a HMBC 
correlation to H-16a and H-16b. The methine resonance at δΗ 3.85 could then be assigned 
to H-11 because of a HMBC to C-13.  Since this proton resonance is situated downfield, 
it suggests the presence of a hydroxyl group at this position even though the 
corresponding carbon resonance at δC 66.19 is not as deshielded as other C-O carbon 
resonances (with chemical shifts between 72-80). 
 
The methylene carbon resonances could not be assigned from the spectra available, 
therefore, literature with NMR data of similar compounds was used to assign them 
(Tables 19 and 20) (Ansell, 1989; Kang et al., 2005). 
 
We have placed the proton at C-3 in the axial/alpha position and the hydroxyl group in 
the beta/equatorial position in accordance with the literature (Ansell, 1989). The 













system where coupling constants of 5.3 Hz and 9.7 Hz indicated an axial proton (α) and 
an equatorial hydroxyl group (β).  The coupling constants of compound III compared 
well to this with values of 3.84 Hz and 10.84 Hz indicating that the hydroxyl group at 
position 3 in compound III was equatorial (β).  This was supported by a NOESY 
correlation between H-3 and H-5 indicating a 1,3-diaxial interaction between the two 
protons. 
 
The NOESY spectrum was then used to determine the configuration of the hydroxyl 
group at C-11 as well as the methyl group situated at C-13.   The methyl group CH3-20ax 
showed a correlation to the proton at H-11 which puts this hydrogen in a beta/axial 
position and the hydroxyl group in the alpha/equatorial position (Figure 18).  It is for this 
reason that the compound III has been named as ent-pimara-8(14),15-diene-3β,11α-diol. 
 
The methyl group, CH3-17 was assigned to the equatorial (alpha) position as it showed 
NOESY correlations with the H-12α proton at δΗ 1.82.  The protons at H-12 was 
assigned using values from the literature of similar compound, 3.3 (Meragelman et al., 
2003) (Table 20, page 117) as compound III in the literature does not distinguish 


































The proton NMR data for compound III was similar to that in the literature with the 
exception of the resonance for the methylene group at C-6 (Table 19).  Ansell (1989) 
reported 2H-6 having a resonance of δΗ 2.37 (ddd, J = 2.3, 3.3, 13.2 Hz) while in 
compound III, the methylene group at C-6 resonated as singlets at δΗ 1.38 and δΗ 1.63 
(Table 19).  The 
13
C NMR data was not reported in the literature and therefore the 
diacetylated compound was used for comparison (Table 19).  Due to insufficient sample, 
compound III could not be acetylated for absolute comparison.   
 
In comparing our compound to that of literature, we have had to make an assumption that 
the compound in the literature had the hydroxyl groups in the equatorial positions (3β and 
11α) as concluded in the discussion and not by what was depicted in the structure. The 
discussion of the compound in Ansell (1989) did not match the structure (where the 
hydroxyl groups were axial, 3α and 11β).  The 13C NMR data also compared well to 






























(J = 3.84, 10.84 Hz) 
3.26, sx 
(J = 5.3, 9.7, Hz) 
78.86 80.6 
*4 C   39.11 38.0 










8 C=C   137.46 136.4 
9 CH 1.61  59.83 55.4 
*10 C   39.05 38.7
 




















11 CH-OH 3.85, m 
3.86, ddd 




1.82 (α)  
45.85 40.7 
1.35 (β)  
*13 C   39.57 38.7 
14 CH= 5.20, s 
5.21, d 




(J = 10.57, 17.21 Hz) 
5.74, sx 




(J = 9.28, 17.4 Hz) 
4.87, dd 
(J = 1.9, 18.1 Hz) 
112.69 112.5 
4.91, dd 
(J = 1.9, 9.5 Hz) 
17 CH3 1.01, s 1.02, s 29.51 29.5 
18 CH3 0.99, s 1.00, s 28.43 28.3 
19 CH3 0.78, s 0.79, s 15.59 15.7 
20 CH3 0.75, s 0.76, s 15.82 16.6 
3 OCOCH3 --- --- --- 170.2 
3 OCOCH3 --- --- --- 21.1 
11 OCOCH3 --- --- --- 170.6 
11 OCOCH3 --- --- --- 21.5 
























Ansell, 1989 Kang et al., 2005 Meragelman et al., 2003 
1 
2.35  2.68,  s 
1.71, dt 
(J = 13.1, 3.5 Hz) 
 2.02   0.98 
2 
1.69   1.61, m 
1.57   1.61, m 
3 
3.26, dd 
(J = 3.84, 10.84 Hz)  
3.31, dd 
(J = 4.5, 9.6 Hz) 
4.0, s 
3.21, dd 
(J =  11.1, 5,2 Hz) 
5 1.08  1.68, m 0.82 


















Ansell, 1989 Kang et al., 2005 Meragelman et al., 2003 
6 
1.63  1.73, m 
1.63, qd 
(J = 13.4, 3.2 Hz) 
1.38   1.49 
7 
1.48  2.13, m 1.22 
1.85  2.35, m 
1.78, dt 
(J = 13.4, 3.2 Hz) 
9 1.61  
2.02, d 
(J = 5.7 Hz) 
0.85 
11 3.85  4.0, m 
1.47 (α), qd 
(J = 13.4, 3.1 Hz) 
1.47 (β), m 
12 1.82  1.63, m 
2.01, dq 
(J = 13.7, 3.1 Hz) 
15 
5.72, dd 
(J = 10.57, 17.21 
Hz) 
5.74, septet 
(J = 18.4, 8.6 Hz) 
5.83, dd 
(J = 10, 17.8 Hz) 
5.98, dd 
(J = 17.9, 11.0 Hz) 
16 
4.89, dd 
(J = 9.28, 17.4 Hz) 
4.90, dd 
(J = 2.1, 18.4 Hz) 
4.94, d 
(J = 10 Hz) 
5.09, dd 
(J = 11.0, 1.2 Hz) 
4.96, dd 
(J = 2.2, 8.5 Hz) 
5.00, d 
(J = 17.8 Hz) 
5.14, dd 
(J =  17.9, 1.2 Hz) 
17 1.01, s *1.09, s 1.05, s 0.91, s 
18 0.99, s *1.10, s 1.19, s 0.99, s 
19 0.78, s *0.84, s 0.69, s 0.81, s 
20 0.75, s *0.92, s 0.80, s 0.93, s 
* Resonance for
 






C NMR data for compound III (CDCl3) compared with two similar 
compounds 
Position Compound III 




Compound 3.3  
(50MHz) 
Ansell, 1989 Kang et al., 2005 Meragelman et al., 2003 
1 35.74 37.3 52.2 37.8 
2 27.59 27.7 211.0 27.2 
3 78.86 79.2 82.2 79.1 
4 39.11 38.3 45.3 38.9 
5 53.99 54.3 53.3 55.6 
6 22.55 22.3 22.3 17.8 
7 38.38 35.8 35.2 42.0 
8 137.46 137.9 134.6 72.3 
9 59.83 51.3 59.1 56.2 




Position Compound III 
Compound 3.1 
 (80MHz) 
Compound 3.2  
(75MHz) 
Compound 3.3  
(50MHz) 
Ansell, 1989 Kang et al., 2005 Meragelman et al., 2003 
10 39.05 38.6 44.7 37.0 
11 66.19 19.2 65.8 17.4 
12 45.85 35.8 44.0 36.1 
13 39.57 38.6 37.8 36.5 
14 127.64 128.3 129.1 53.4 
15 146.18 147.4 148.3 147.5 
16 112.69 112.8 110.9 112.0 
17 29.51 29.5 26.5 28.3 
18 28.43 28.5 29.3 32.4 
19 15.59 15.7 16.4 15.5 














































































































Compound IV is a white compound soluble in methanol with a melting point of 255°C 
and an optical rotation of [ ]20Dα +32.26° (c 0.0186g/100ml, MeOH).  A molecular ion peak 
of m/z 488 was anticipated as this molecular weight corresponded to the molecular 
formula of compound IV, C30H48O5.   This peak could not be detected on the mass 
spectrum but a fragment ion peak of m/z 426 and a base peak of m/z 218 were 
documented.  The loss of one of the hydroxyl (-OH) group together with the carboxylic 
acid (-COOH) group, accounts for the fragment ion peak of m/z 426.  Tertiary alcohols 
and carboxylic acids seldom show the molecular ion peaks in the mass spectrum.  The IR 
spectrum showed O-H stretching bands at 3424 cm
-1
, C-H stretching vibrations at 2927 
cm
-1 
and a stretching band at 1687 cm
-1
 which is suggestive of a carboxylic acid group 
since this group has less double bond character than an aliphatic ketone.  The UV 
spectrum showed a maximum absorbance at a wavelength of 211nm (log ε = 2.05).   The 
UV spectra of pentacyclic triterpenoids with a single double bond, a carboxylic acid 





H NMR spectrum in conjuction with the HSQC and DEPT spectrum showed the 
presence of seven methyl resonances at δΗ 0.78 (s), δΗ 0.86 (s), δΗ 0.92 (d, J = 7.8 Hz), 




resonance at δΗ 5.29 and two oxygenated methine resonances at δΗ 3.33 (d, J = 2.28 Hz) 
which overlapped with the solvent peaks and δΗ 3.93, a broad doublet of triplets 
respectively.   
 
The two characteristic olefinic resonances at δC 127.95 (CH=) and δC 138.66 (C=) 
suggested an urs-12-ene skeleton.  However the tertiary methyl group (3H-28) which is 
usually present at C-17 in urs-12-ene triterpenes was replaced by a carboxylic acid group 
evidenced by the carbonyl resonance of the carboxyl group at δC 180.88.  The C-17 
carbon resonance overlapped with the resonances of the deuterated methanol solvent 
peak between δ 47 and δ 48 and showed HMBC correlations to a methylene and methine 
resonance at δΗ 2.57 (2H-16) and δΗ 2.49 (H-18), respectively.  The proposed resonance 
for quartenary carbon C-17, falls within the range as documented for similar compounds 
4.1, 4.4 and 4.5 (Table 23). 
 
The two proton resonances at δH 3.93 and δH 3.33 were attributed to H-2ax and H-3eq 
respectively based on a comparison with the C-17 methylated compounds, where H-2 and 
H-3 are axial and equatorial respectively (Lontsi et al., 1992) and where H-2 and H-3 are 
both axially situated (Lontsi et al., 1998).  Our compound compared favourably with the 
H-2ax and H-3eq configuration.  The corresponding carbon resonances at δC 65.90 (C-2) 
and δC 78.70 (C-3) are deshielded owing to the oxygenation at these carbons. 
 
In addition to C-2 and C-3, a further deshielded carbon resonance at δC 72.18 suggested 
the presence of another oxygenated group.  This carbon resonance was however 
quaternary and was placed at C-19 with a hydroxyl and methyl attached to it.  Literature 
supported this assignment as C-19 in the literature with the same substitution pattern 
resonates between δ 71 and δ 74, Table 22 (da Graca Rocha et al., 2007; Fang et al., 
1991; Lontsi et al., 1992; 1998).    
 
The C-3 carbon resonance showed HMBC correlations to two tertiary methyl resonances, 




showed HMBC correlations to another methine resonance and one quartenary carbon 
resonance at δC 47.90 and δC 38.07, which were then attributed to C-5 and C-4, 
respectively.   
 
The quartenary carbon resonance at δC 39.86 (C-8) showed correlations to two tertiary 
methyl resonances at δH 1.35 and δH 0.78 which were assigned as 3H-27 and 3H-26, 
respectively.   The 3H-27 methyl resonance was then used to assign the quaternary 
carbon resonance of C-14 and the methylene resonance of C-15 to δ 41.35 and δ 28.21 
due to HMBC correlations. 
 
The C-19 carbon resonance showed HMBC correlations to two methyl resonances at δH 
1.19 and δH 0.92 (d, J = 7.8 Hz), which were then attributed to 3H-29eq and 3H-30eq 
respectively.  The two methyl groups were distinguished as the resonance at δH 0.92 was 
a doublet and had to be situated at C-20, which was assigned to δC 41.73 because of a 
HMBC correlation to 3H-29 and 3H-30.  The H-18 methine resonance could also be 
assigned because of a HMBC correlation to C-19. 
 
In addition to the HMBC correlation to C-8, 3H-26 showed correlations to the carbon 
resonances at δC 32.68 and δC 46.79 which were then assigned to C-7 and C-9 
respectively.  The distinction between the two was made as δC 32.68 was a methylene 
carbon resonance and δC 46.79 was a methine carbon resonance.   The C-9 carbon 
resonance in turn was used to assign 3H-25, the remaining methyl resonance as C-9 
showed HMBC correlations to it.  The 3H-25 methyl resonance then showed a HMBC 
correlation to δC 41.09 which was then attributed to C-1. 
 
The carboxylic acid carbon resonance at δC 180.88 and the two olefinic carbon 
resonances at δC 127.95 and δC 138.66 showed correlations to H-18 and were assigned to 
C-28 of the carboxylic acid group and C-12 and C-13 of the double bond. The quaternary 




HMBC correlation with H-18.  The H-18 resonance was also used to assign the 
methylene proton resonance of 2H-16 due to HMBC coupling with this resonance.   
 
The remaining methylene carbon resonances of C-6, C-11, C-21 and C-22 were assigned 
using literature values (Table 22) (da Graca Rocha et al., 2007; Fang et al., 1991; Lontsi 
et al., 1992; 1998).  We think that da Graca Rocha et al. (2007) has incorrectly assigned 
C-15 and C-21 and that these values are in fact switched around.  We have based our 
assignment of C-15 on a HMBC correlation with 3H-27.   
 
Compounds having the ursene skeletal structure posess seven methyl groups with the 
orientation of five methyl groups (3H-23 to 3H-27) being certain as a result of 
biosynthesis and two methyl groups (3H-29 and 3H-30) being either alpha or beta.  To 
determine the stereochemistry of these two methyl groups as well as the two oxygenated 
methines (H-2 and H-3), correlations in the NOESY spectrum was used, in conjunction 
with a molecular model. 
  
The H-2 proton resonance at δΗ 3.93 showed correlations to the H-3, 3H-24ax (δΗ 0.86) 
and the overlapping methyl group resonances of 3H-23eq and 3H-25ax at δΗ 0.98.  We 
have assumed that H-2 correlates to the resonance of 3H-25ax since this 3H-25ax is closer 
in proximity to H-2.  Thus, H-2, based on this correlation would be axial and beta and 
since there is a NOESY correlation between H-2 and H-3, H-3 must also be beta and 
equatorial.  All these NOESY correlations were also observed as possible on a molecular 
model.   
 
Assuming that all the rings in the molecule are in the more stable chair conformation, H-
18 would be in the axial/alpha position.  A NOESY correlation between H-18ax and 3H-
27 confirms the methyl group (CH3-27) to be axial/alpha and a further correlation 
between H-18ax and 3H-29 puts the methyl group (CH3-29) in the alpha/equatorial 







































Figure 19: NOESY correlations for compound IV 
 
Based on the analytical data reported for compound IV as well as the comparison of this 
data with literature, compound IV was identified as 2α,3α,19α-trihydroxyurs-12-en-28-
oic acid (Table 22).  A slight difference with regard to chemical shift has been obeserved 
between compound IV and the reference compound (Table 22).   
  




















1.28  41.09 
37.2 
1.56   
2 CH 3.93, dt 
(J = 3.72, 3.18 
4.10, m 65.90 64.6 
3 CH 
3.33, d 
(J = 2.28 Hz) 
3.90, d 78.70 77.9 
4 C   38.07 41.6 









8 C   39.86 41.1 
9 CH 1.85  46.79 47.6 
10 C   37.99 38.1 
11 CH2 2.00  23.41 25.1 
12 CH= 
5.29, t 
(J = 3.72 Hz) 
a
5.20, s 127.95 126.9 
13 C=C   138.66 138.6 






















14 C   41.35 40.7 
15 CH2 
1.01  
 28.21 25.9 1.79  
16 CH2 
1.51  
 25.25 23.1 2.57  
17 C   47-48 46.8 
18 CH 2.49  53.66 53.1 
19 C   72.18 71.6 
20 CH 1.35  41.73 41.4 
21 CH2 
1.23  
 25.96 29.0 1.73  
22 CH2 
1.61  
 37.65 38.0 1.71  
23 CH3 0.98 0.69, s 27.89 28.9 
24 CH3 0.86 1.30, s 21.09 21.8 
25 CH3 0.98 0.89, s 16.15 16.3 
26 CH3 0.78 0.95, s 15.51 16.1 
27 CH3 1.35 1.22, s 23.55 24.1 
28 COOH   180.88 178.9 
29 CH3 1.19 1.06, s 25.68 26.4 
30 CH3 0.92, d 
(J = 7.8 Hz) 
0.90, d 15.25 16.6 
*  coupling constants not documented 
a
   Reported as resonance for H-5 by De Graca Rocha et al. (2007) but suspect that this resonance belongs to 
H-12  
b






C NMR data of three previously isolated compounds (da Graca Rocha et 
al., 2007; Lontsi et al., 1998; Fang et al., 1991) were compared with that of compound 
IV (Tables 23 and 24) as they closely resemble euscaphic acid, the differences being the 
orientation of the hydroxyl group at C-3 and C-11 as well as the substituent at the C-17 
position.  Once again it should be noted that reference compounds 4.1 to 4.3 were 































































Table 23: Comparison of 
13





4.1 4.2 4.3 
b
da Graca 
















Lontsi et al., 
1998 
(75MHz) 
1 41.09 39.1 47.7 41.7 41.4 46.34 
2 65.9 67.1 68.4 66.5 77.2 68.47 
3 78.70 82.3 83.2 78.9 78.6 83.25 
4 38.07 41.4 39.1 38.2 39.9 39.14 
5 47.95 53.1 55.0 48.0 53.0 55.05 
6 17.93 18.1 18.3 18.1 17.9 18.28 
7 32.68 32.6 32.4 32.5 32.3 32.44 
8 39.86 42.4 39.7 40.1 41.0 39.72 
9 46.79 46.7 47.7 46.9 47.7 46.95 
10 37.99 37.6 37.9 38.3 37.3 37.94 
11 23.41 25.2 23.5 23.6 23.5 23.54 
12 127.95 126.7 128.5 129.0 128.8 128.59 
13 138.66 138.9 138.0 138.1 138.0 137.99 
14 41.35 40.7 41.0 41.2 41.0 40.99 
15 28.21 30.4 25.8 28.1 28.0 27.99 
16 25.25 25.1 25.2 25.4 25.3 25.23 
17 47-48 47.0 46.3 47.9 47.8 47.68 
18 53.66 54.8 53.0 53.2 51.5 53.02 
19 72.18 71.7 72.8 73.1 72.9 72.83 
20 41.73 41.4 41.0 41.1 46.7 40.99 
21 25.96 28.1 28.0 26.0 25.3 25.83 
22 37.65 39.1 37.2 37.4 37.3 37.24 







4.1 4.2 4.3 
b
da Graca 




























24 21.09 17.1 16.7 21.8 21.8 16.72 
25 15.51 16.6 16.4 16.2 16.1 16.36 
26 16.15 23.3 16.7 16.6 17.9 16.42 
27 23.55 24.0 224.3 24.7 24.6 24.37 
28 180.88 179.0 178.2 178.2 178.4 178.26 
29 25.68 26.4 28.0 27.4 27.2 27.18 
30 15.25 16.5 15.9 16.1 16.5 15.97 
COOCH3 -- -- 51.4 51.6 66.2 51.46 
a








Table 24: Comparison of 
1
H NMR data of compound IV (600MHz, CD3OD) with three 
reference compounds  
Position Compound IV 
4.1 4.2 4.3 
b #




Lontsi et al., 1992 
(300MHz) 
a
Lontsi et al., 1998 
(300MHz) 
1 










(J = 3.72, 3.18 Hz) 
4.10, m 
3.97, ddd 
(J = 11.8, 4.4, 2.8 Hz) 
3.36, ddd 
(J = 14.7, 9.5, 4.7 Hz) 
3 
3.33, d 
(J = 2.28 Hz) 
3.91, s 
3.40, d 
(J = 2.8 Hz) 
2.98, d 
(J = 9.5 Hz) 
5 1.26   0.81, m 
6 
1.39   1.32, m 
1.45   1.52, m 
7 
1.31   1.26, m 
1.58   1.50, m 
9 1.85  1.70, m 1.65, m 
11 2.00  1.96, m 1.98, m 
12 
5.29, t 
(J = 3.72 Hz) 
*5.19, s 
5.33, dd 
(J = 3.6, 3.5 Hz) 
5.33, dd 
(J = 3.6, 3.6 Hz) 
15 
1.01   1.00, m 
1.79   1.60, m 
16 
1.51   1.56, m 
2.57  
2.49, ddd 
(J = 13.7, 11.5, 4.7 Hz) 
2.49, ddd 
(J = 14.5, 12.6, 4.8 Hz) 
18 2.49  2.57, s 2.57, s 




Position Compound IV 
4.1 4.2 4.3 
b #




Lontsi et al., 1992 
(300MHz) 
a







1.23   1.25, m 
1.73   1.66, m 
22 
1.61   1.52, m 
1.71   1.72, m 
23 0.98  0.99, s 1.01, s 
24 0.86  0.84, s 0.80, s 
25 0.98  0.93, s 0.95, s 
26 0.78  0.64, s 0.65, s 
27 1.35  1.23, s 1.23, s 
29 1.19  1.18, s 1.19, s 
30 0.92, d 
(J = 7.8 Hz) 
 0.92, d 
(J = 6.6 Hz) 
0.92, d 
(J = 6.7 Hz) 28-
OCH3 
  3.57, s 3.58, s 
NB  
1
H NMR data for compounds 4.2 and 4.3 were not documented by Fang et al. (1991) 
*      Reported as resonance for H-5 by da Graca Rocha et al. (2007) but suspect that this resonance belongs to 
H-12  
#
      coupling constants not documented 
a
      CDCl3  
b
     DMSO 
 
 





































Compound V is a white compound soluble in both dichloromethane and methanol having 






D -40.8° (c 0.12g/100ml, CDCl3).  The IR spectrum showed O-H stretching bands 
at 3305 cm
-1
, C-H stretching vibrations at 2932 cm
-1
 and alkene stretching bands at 1641 
cm
-1




H NMR spectrum showed the characteristic pattern of the ubiquitous stigmasterol 
with the three olefinic proton resonances at δH 4.99 (dd, J = 8.64, 15.2 Hz, H-22), δH 5.13 
(dd, J = 8.56, 15.2 Hz, H-23) and δH 5.32 (bd, J = 5.04 Hz, H-6) and the deshielded 
methine resonance at δΗ 3.49 (m, H-3), owing to the hydroxy group at this position.  On 
closer examination of the methyl group region of the 
1
H NMR spectrum and in 
comparison with the literature (Langlois, 2000), the methyl groups numbered as 18, 19, 
21, 26, 27 and 29 were assigned to δH 0.65, 0.67, 0.99 (d, J = 8.12 Hz), 0.89 (d, J = 7.18 




C NMR spectrum indicated the presence of characteristic olefinic resonances at δC 
121.71 (C-6), δC 129.29 (C-23), δC 138.31 (C-22) and δC 140.76 (C-5).  The deshielded 
oxygenated methine carbon resonance of C-3 occurred at δC 71.81.  Compound V was 




C NMR spectra of 
an authentic sample in the laboratory.  The NMR data also compared well with that in 
literature (Langlois, 2000; Kongduang et al., 2008)    
 
Compound VI is a white compound soluble in both dichloromethane and methanol 
having a molecular formula of C30H50O.   It has a melting point of 214°C and an optical 
rotation of [α]
20
D +25.3° (c 1.2g/100ml, CDCl3).  The IR spectrum showed O-H 
stretching bands at 3332 cm
-1
, C-H stretching vibrations at 2941 cm
-1
 and alkene 
stretching bands at 1637 cm
-1




H NMR spectrum showed characteristic resonances for the well known pentacyclic 
triterpenoid, lupeol with the characteristic olefinic proton resonances at δH 4.57 (brs, H-
29α) and δH 4.69 (brs, H-29β), one deshielded methine group resonance at δΗ 3.19 (dd, J = 




multiplet at δH 1.91 (H-21) and a very shielded doublet at δH 0.68 (J = 9.12 Hz, H-5) 
(Makatini, 2007).  The methyl groups identified as 3H-23 (δH 0.97), 3H-24 (δH 0.76), 3H-
25 (δH 0.83), 3H-26 (δH 1.03), 3H-27 (δH 0.94), 3H-28 (δH 0.79) and a methyl group 




C NMR spectrum indicated the presence of thirty carbons with characteristic 
olefinic resonances at δC 150.98 (C-20) and δC 109.33 (C-29).  The C-3 and C-5 carbon 
resonance could also be singled out at δC 79.01 and δC 55.30, respectively, Compound VI 
was identical to an authentic sample of lupeol with regard to physical appearance, 
melting point, optical rotation and IR spectroscopy.  A comparison of the NMR data of 
compound VI with that documented by Burns et al. (2000) for lupeol, also proved that 













Compound V Langlois, 2000 Compound V 
Kongduang et al., 2008 
(125MHz) 
1   37.26 37.21 
2   31.66 231.62 
3 3.49, m 3.50, m 71.81 71.80 
4   42.31 42.18 
5   140.76 140.72 
6 5.32, bd 5.35, brs 121.71 121.71 
7   31.87 31.87 
8   31.91 31.87 
9   50.15 50.08 
10   36.51 36.48 
11   21.08 21.07 
12   39.68 39.64 
13   42.32 42.29 
14   56.87 56.83 
15   24.36 24.34 
16   28.91 28.92 
17   55.96 55.90 
18 0.65, s 0.66, s 12.04 12.03 
21 
0.99, d 
(J = 8.12 Hz) 
1.00, d 
(J = 6.65 Hz) 
21.21 21.05 









Compound V Langlois, 2000 Compound V Kongduang et al., 2008 
19 0.67, s 0.70, s 19.39 19.38 
20   40.48 40.50 
22 
4.99, dd 
(J = 8.56, 15.12 Hz)  
5.00, dd 
(J = 7.60, 15.38 Hz) 
138.31 138.32 
23 
 5.13, dd 
(J = 8.64, 15.16 Hz) 
5.15, dd 
(J = 11.53, 15.38 Hz) 
129.29 129.22 
24 2.25, m 2.21, m 51.24 51.21 
25   32.42 31.87 
26 
0.89, d 
(J = 7.18 Hz) 
0.90, d 




(J = 6.24 Hz) 
0.78, d 
(J = 6.35 Hz) 
18.98 18.95 
28   25.40 25.40 
29 
0.82, t 
(J = 6.28 Hz) 
0.80, t 
(J = 6.5 Hz) 
12.24 12.25 
NB. Langlois (2000) did not report the 
13
C NMR data for stigmasterol  
        Kongduang et al. (2008) did not report the 
1
















Burns et al., 2000 
(500MHz) 
Compound VI 












(J = 5.04, 11.17 Hz) 
3.19 79.01 79.02 
-OH  1.26   
4   38.86 38.87 
5 
0.68, d 
(J = 9.12 Hz) 





7  1.39 34.29 34.29 
8   40.84 40.84 
9  1.27 50.44 50.35 









13  1.66 38.06 38.07 










Burns et al., 2000 
(500MHz) 
Compound VI 
Burns et al., 2000 
(500MHz) 









17   43.00 43.01 
18  1.36 47.99 48.32 
19 
2.38, dt 
(J = 5.88, 11.03 Hz) 
2.38 48.31 48.00 









23 0.97, s 0.97 27.99 28.00 
24 0.76, s 0.76 15.38 15.38 
25 0.83, s 0.83 16.12 16.13 
26 1.03, s 1.03 15.98 15.99 
27 0.94, s 0.95 14.55 14.56 
28 0.79, s 0.79 18.01 18.02 
29 
4.57, brs 4.56 
109.33 109.32 
4.69, brs 4.69 





Physical data for compounds I-VI 
 
Compound I  
Chemical name: 7β-acetoxy-6β,12-dihydroxy-8,12-abietadiene-11,14-dione 
Common name: 7β-acetoxy-6β-hydroxyroyleanone 
Molecular formula: C22H30O6 





C, Mehrotra et al., 1989) 
Optical rotation: [ ]20Dα +29
o 
(c 0.0052g/100ml, DCM) (lit. value = +23
o
 (CHCl3; Cl), 






: 3377 (O-H stretching bands), 1734 (carbonyl stretching 
bands), 1375 (C-H stretching vibrations), 1641 (alkene stretching bands) 
Ultraviolet spectrum (λ max):  275 nm (log ε = 1.61) 
GC-MS (70eV, direct inlet), relative intensity %: m/z 390 (1.46) [M]
+
, m/z 372 (4.85) [M 
– H2O]
+
, m/z 357 (0.97) [M - H2O - Me]
+
, m/z 71 (100) 
1
H NMR and 
13




Compound II:  
Chemical name: 6β,7β,12-trihydroxy-8,12-abietadiene-11,14-dione 
Common name: 6β,7β-dihydroxyroyleanone 
Molecular formula: C20H28O5 





C, Hensch et al., 1975) 
Optical rotation: [ ]20Dα -47
o 
(c 0.0063g/100ml, DCM) (lit. value = -77
o







: 3369 (O-H stretching bands), 1376 (C-H bending 




Ultraviolet spectrum (λ max): 192nm (log ε = 2.73) 
LC-MS (70eV, direct inlet):  [M]
+




C NMR data (CDCl3, 400MHz): Refer to tables 17 and 18 on pages 111 and 112  
 
 
Compound III:   
Chemical name: ent-pimara-8(14),15-dien-3α,11β-diol 
Physical description: white residue 





C, Ansell, 1989) 






: 3396 (O-H stretching bands), 2930 (C-H stretching 
vibrations)  
Ultraviolet spectrum (λ max): 228nm (log ε = 1.70) 
GC-MS (70eV, direct inlet), relative intensity %: m/z 304 (1.94) [M]
+
, m/z 135 (100), m/z 
286 (10.68) [M – H2O]
+




H NMR and 
13
C NMR data (CDCl3, 400MHz): Refer to table 19 on page 116 
 
 
Compound IV:    
Chemical name: 2α,3α,19α-trihydroxyurs-12-en-28-oic acid 
Common name: euscaphic acid, jacarandic acid 
Molecular formula: C30H48O5 










: 3424 (O-H stretching bands), 2927 (C-H stretching bands), 
1687 (C=O) 




GC-MS (70eV, direct inlet), relative intensity %: m/z 426 (8.56) [M - COOH - OH]
+
,  m/z 
218 (100)  
1
H NMR and 
13
C NMR data (CD3OD, 600MHz): Refer to table 22 on page 124 
 
 
Compound V:    
Chemical name: 5,22-Stigmastadien-3β-ol 
Common name: Stigmasterol 
Molecular formula: C29H42O 





C, Jamal et al., 2009) 








(O-H stretching bands), 2932 cm
-1
 (C-H 
stretching vibrations), 1641 cm
-1
 (alkene stretching bands) 
1
H NMR and 
13
C NMR data: Refer to table 25 on page 130 
 
 
Compound VI:  
Chemical name: lup-20(29)-en-3β-ol 
Common name: Lupeol    
Molecular formula: C30H50O 





C, Fotie et al., 2006; 214-215
o
C, Saeed et al., 2003) 
Optical rotation: [ ]20Dα +25.3° (c 1.2g/100ml, DCM) (lit. value = +25.7° (c 0.70, CHCl3), 








(O-H stretching bands), 2941 cm
-1
 (C-H 
stretching vibrations), 1637 cm
-1
 (alkene stretching bands)  
1
H NMR and 
13
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Chapter 4 Antibacterial and anticancer activity of the 
compounds isolated 
 
The compounds isolated were tested for their antibacterial and anticancer activity in 
collaboration with the CSIR as these biological screens were available at the time.  The 
bacterial strains used were the Gram-negative Pseudomonas aeruginosa American Type 
Culture Collection 25922 (ATCC25922) and the Gram-positive Enterococcus faecalis 
(ATCC29212) whilst breast (Michigan Cancer Foundation – Seventh sample (MCF-7)), 
renal (TK-10) and melanoma (UACC-62) cell lines were assayed for anticancer purposes. 
 
There is no record of antibacterial, antifungal or anticancer testing being done on 
compounds I to IV.  However, compounds 33 (6β,7α-dihydroxyroyleanone) and 36 (7α-
acetoxy-6β-hydroxyroyleanone) which are 7α-isomers of compounds I and II 
respectively, have proven to posess antibacterial activity against six strains of methicillin 
resistant Staphylococcus aureus (MRSA), two strains of vancomycin-resistant 
Enterococcus faecalis (VRE), Bacillus subtilis, Staphylococcus aureus, Vibrio cholera 
and Xanthomonas campestris (Laing et al., 2006; Teixera et al., 1997; Gaspar-Marques et 
al., 2006),  antifungal activity against Rhizoctonia solani, Sclerotinia sclerotiorum, 
Pythium ultimum and an unknown Candida species (Laing et al., 2006; Teixera et al., 
1997; Gaspar-Marques et al., 2006), anticancer activity against human lymphocytes 
induced by phytohaemagglutinin (PHA) and expression of CD69 by T- and B- mouse 
lymphocytes, antitumor activity against human cancer cell ines MCF-7, NCI-H460, SF-
268, TK-10 and UACC-62 (Cerqueira et al., 2004; Gaspar-Marques et al., 2002) and 
antimalarial activity against Plasmodium falciparum (van Zyl et al., 2008) (Tables 12 and 
14).   
 
Compound V has been isolated twice before from the Plectranthus species (Simoes, 
2010; Yao, 2002) but this is the first time that it has been isolated from P. hadiensis.  





Since the 7α-isomers of compounds I and II (36 and 33, respectively) exhibited the 
above mentioned activity, it was decided to determine the antibacterial activity and 
anticancer activity of these two compounds.  The bacterial strains tested were that of E. 
faecalis and P. aeruginosa with the hope of these two compounds exhibiting greater 
activity than that reported in literature where 33 and 36 (having MIC values of 
62.50µg/mL and 31.25µg/mL and 15.63µg/mL and 31.25µg/mL against two VRE strains, 
respectively) displayed stronger activity against VRE than vancomycin (having a 
minimum MIC value of 125µg/mL) and where 36 displayed more potent activity against 
MRSA (with MIC values averaging 7.8µg/mL) than oxacillin (having a MIC value of 
15.63µg/mL) (Gaspar-Marques et al., 2006).  The 7-acetoxy function also proved 
superior in activity to the 7-hydroxy function when tested for anticancer activity against 
MCF-7, NCI-H460, SF-268, TK-10 and UACC-62 cell lines (Gaspar-Marques et al., 
2002).  The purpose of the anticancer testing performed in this study was to see how the 
isomers of 36 and 33, I and II respectively, faired in the anticancer assays.         
 
Even though, compound III has been isolated by Ansell (1989) there hasn’t been any 
report of this compound showing biological activity.  The only report of an ent-pimarene 
displaying antibacterial activity was by Porto et al. (2009) where ent-8(14),15-
pimaradien-3β-ol was found to be active against E. faecalis having an an MIC value of 
20µg/mL.  It is still unknown as to whether ent-pimarene compounds possess anticancer 
activity as they have not been tested against any cell lines to date.  
 
There were three reports of anticancer testing of compound IV, however none of these 
studies tested for activity against the TK-10 (renal) and UACC-62 (melanoma) cell lines.  
Cheng et al. (2010) tested compound IV for activity against four human cancer cell lines 
(MCF-7, tested in this work, NCI-H460, HT-29 and CEM) (Cheng et al., 2010).  The 
results indicated that this compound was inactive as an anticancer agent based on cancer 
cell proliferation (Cheng et al., 2010).  Studies by Ogura et al. (1977) and Mujovo (2010) 
proved that compound IV does possess anticancer activity by testing positive for activity 




cytotoxic activity against monkey kidney Vero cell lines, having IC50 values ranging 
between 4.52µg/mL and 19.21µg/mL (Mujovo, 2010).     
 
 
4.1 Antibacterial testing  
Compounds I to IV (7β-acetoxy-6β-hydroxyroyleanone (I), 7β,6β-dihydroxyroyleanone 
(II), ent-pimara-8(14),15-diene-3β,11α-diol (III) and 2α,3α,19α-trihydroxyurs-12-en-28-
oic acid (IV)) were sent to the Council for Science and Industrial Research (CSIR) in 
Pretoria, South Africa to be assessed for their antibacterial activity.  The bacterial strains 
used were the Gram-negative Pseudomonas aeruginosa (ATCC25922) and the Gram-




The samples were dissolved in acetone to a known concentration (1.0 mg/mL) prior to 
being tested, with the exception of compound IV which was prepared to a concentration 
of 0.8 mg/mL due to there being insufficient sample.  The antibacterial assays followed 
the format of the serial microdilution assay (Eloff, 1998).  In brief, two-fold serial 
dilutions of the samples were carried out and made up to 100µL in 96-well microtitre 













































































being incubated for 24 hours at 37°C.  A volume of 40µL of 0.2mg/mL 
Iodonitrotetrazolium chloride (INT, Sigma) was added to each well as indicator of 
bacterial growth.  INT, a colourless tetrazolium salt, is converted to a red-coloured 
formazan product by actively dividing cells.  The minimum inhibitory concentration 
(MIC) was visually read as the lowest concentration of sample that inhibited microbial 
growth, as indicated by a visible reduction in the red colour of the INT formazan.  In each 
assay, a negative solvent control and a positive control of the antibiotic was used.  
Gentamicin (Sigma) was used as the antibacterial control and the samples were tested in 
triplicate.   
 
4.1.2 Results and discussion 
The results of the Minimum Inhibitory Concentration (MIC) determinations of the four 
compounds against Enterococcus faecalis and Pseudomonas aeruginosa are given in 
Table 27.  MIC values for the samples and the reference antibiotic, gentamicin are 
reported in µg/mL. 
 
Table 27: Antibacterial activity of compounds I to IV 
Compound 
Average MIC (µg/mL) 
24 hours 
E. faecalis P. aeruginosa 
I 62.50 62.50 
II 31.30 7.80 
III 125.00 15.60 
IV 200.00 200.00 
Gentamicin 0.39 0.78 
 
The antibacterial activity of compounds I to IV were evaluated relative to gentamicin.  
The lower the MIC value, the better the antibacterial activity of the compound.  Since the 
MIC value for gentamicin is below 1µg/mL for both the bacterial strains tested, 
compounds with MIC values below 10µg/mL were noted to be potent antibacterial agents 
while compounds having MIC values between 10µg/mL and 100µg/mL were considered 




and 125µg/mL were categorised as being moderately active.  MIC values above 
125µg/mL suggested poor activity.    
 
Of the four compounds tested for activity against E. faecalis and P. aeruginosa, 
compound IV was the only compound which showed poor activity against both 
microorganisms, having MIC values of 200µg/mL.  This compound however was 
structurally different to the other three, being a tetracyclic triterpenoid whilst the other 
three compounds were abietane diterpenoids.  In the assay against E. faecalis, compound 
III exhibited moderate activity having a MIC value of 125µg/mL.  Compounds II and III 
showed good antibacterial activity with royleanone II, having a hydroxy group at 
position 7, having the highest activity at 31.30µg/mL.   
 
With regard to P. aeruginosa the highest activity (regarded as potent) was shown by 
compound II, the royleanone with the hydroxy group at position 7.  In comparison to it’s 
acetylated counterpart, compound I, it was eight times more active.  The pimarane, ent-
pimara-8(14),15-diene-3β,11α-diol (III), was also very active with a MIC value of 
15.60µg/mL.   
 
In general, the abietanes showed good to potent activity against both strains being more 
active against P. aeruginosa than E. faecalis, with the highest activity being shown by 
compound II (7β,6β-dihydroxyroyleanone). The acetyl group at position 7 of compound 
I seemed to lower the activity in both bacterial strains in relation to the unacetylated 
compound II. 
 
In comparison to the antibiotic gentamicin, compounds I-III are less potent, however 
they may have less side effects and be less toxic than standard antimicrobials used in the 
drug industry and are worth being investigated for development into a new range of 
antibiotics. 
 
Compounds I (7β-acetoxy-6β-hydroxyroyleanone) and II (7β,6β-dihydroxyroyleanone) 




This indicated that the dihydroxy compound had better activity than its monoacetylated 
counterpart.  This is different from that in the literature where the dihydroxy isomer (33) 
showed worse activity with MIC values of 62.50 and 31.25µg/mL than the isomer of the 
acetylated compound (36) with MIC values of 15.63 and 31.25µg/mL against two strains 
of vancomycin-resistant E. faecalis. Even though our compounds displayed weaker 
activity than the antibiotic, gentamicin, they do exhibit stronger activity than that reported 
for vancomycin in Gaspar-Marques et al. (2006). 
 
 
4.2 Anti-cancer screening  
An in-house test method which was developed by the CSIR was employed for the 
evaluation of the anticancer activity of compounds I to IV.  This test method was 
implemented by the CSIR in 1999 and is known as the three cell prescreening method 
(Fouche et al., 2006; 2008).  Breast (MCF-7), renal (TK-10) and melanoma (UACC-62) 
cell lines were three human cell lines chosen for anticancer testing due to their high 
sensitivity to detect anticancer activity (Fouche et al., 2008).   Compounds need to 
demonstrate growth inhibitory activity in this pre-screen panel before proceeding to 
advanced testing in the full 60-cell-line screen. 
Melanoma refers to cancer of the skin and occurs when a UV photon strikes a 
chromophore in a skin cell. A chromophore is the part of a molecule which gives it 
colour.  When the chomophore is struck by the UV photon, a singlet oxygen (
1
O2) or 
hydroxyl (•OH) free radical is produced, which then travels about the body until it finds a 
home in a melanocyte, where DNA is mutated by means of oxidation. The damaged 
melanocyte then becomes a malignant tumour, which is apparent by a change in skin 
colour, usually to a darker shade.  Genetic predisposition, excessive, unprotected 
exposure to the sun as well as the use of tanning or sun beds are some of the factors 
which lead to the formation of melanomas. 
Breast cancer is a form of cancer which originates from breast tissue, commonly found in 




Breast cancer can develop in both males and females and is detectable by means of self-
examination of the breast area.  The presence of lumps or masses in this area is usually an 
indication of cancerous matter, however a mammogram which is performed at most 
medical centres, must be done to confirm the presence of such matter.  Prognosis and 
survival rate varies greatly depending on cancer type and staging.  Treatment includes 
surgery, drugs (hormonal therapy and chemotherapy) and radiation. 
Renal cancer otherwise known as renal cell carcinoma refers to cancer of the kidney.   
Since the kidney is responsible for the filtration of blood and removal of waste products 
from the body, renal cell carcinoma affects the lining of the small tubes within the kidney 
which in turn affects the filtering system.  Unfortunately renal cancer is not detected as 
easily as breast cancer is.  Chronic fatigue, hypertension, fever, presence of blood in the 
urine, pain in the side or lower back as well as a mass or lump in the abdomen are a few 
of the signs and symptoms associated with this cancer.  Chemotherapy, radiation therapy 
and surgery are some of the treatment options available to patients diagnosed with this 
particular cancer.         
 
4.2.1 Experimental 
In the three cell prescreening method, the three cell lines were grown in Roswell Park 
Memorial Institute 1640 (RPMI 1640) medium containing 5% fetal bovine serum and 
2µM L-glutamine.  The cells were then inoculated into 96-well microtiter plates with 
densities ranging between 5,000 and 40,000 cells per well.  A volume of 100µL of the 
medium was introduced into the microtiter plates and subsequently incubated at 37
o
C in a 
5:95 (carbon dioxide:air) atmosphere with 100% relative humidity for 24 hours.   
 
Compounds I-IV were dissolved in dimethyl suphoxide (DMSO) and then added to the 
cells at concentrations ranging between 0.001µg/ml and 100µg/ml.  These cells were then 
incubated for a further 48 hours at 37
o
C in a humidified atmosphere, followed by the 
fixing of the cells in situ with trichloroacetic acid (TCA) and staining with 100µL 




acetic acid and air drying the plates.  Bound stain was solubilized with 10µM trizma base 
and the optical density was read on an automated plate reader at a wavelength of 540nm.   
 
The percentage growth of human tumor cells was determined spectrophotometrically by 
measuring the difference in optical density of the control (C) at the start (T0) and end of 
drug exposure (T).  If T≥T0 either no effect is experienced or inhibition occurs.  Inhibition 
occurs if T<C and no effect is experienced if T=C (Monks et al., 1991; Guerrero et al., 
2006).  Dose-response parameters GI50 (the concentration at which the growth of the cell 
is inhibited by 50%) and LC50 (the concentration at which 50% of the cells are killed) are 
calculated using T, T0 and C where GI50 is calculated as 100 x [(T-T0)/(C-T0)] = 50 and 
LC50 is calculated as 100 x [(T-T0)/(C-T0)] = -50 (Guerrero et al., 2006).  The total 
growth inhibition (TGI) value symbolizes cytostatic activity and refers to the 
concentration at which total cell growth is inhibited.  This value is calculated in much the 
same maner as the GI50 value: 100 x [(T-T0)/(C-T0)] = 0 (Fouche et al., 2008).  The 
calculations of the dose-response parameters required for plotting the dose-response 
curves, were performed by the CSIR.  
 
4.2.2 Results and discussion 
The results are presented as dose-response curves where the net percentage growth (PG) 
is represented on the vertical (y) axis and the concentration for each cell line (expressed 
in µg/mL) is represented on the horizontal (x) axis.  The response parameters GI50, TGI 
and LC50 are interpolated values from these graphs, representing the concentrations at 
which net percentage growth is +50, 0 and -50, respectively (Moodley, 2004).  The 
interpolated values have been determined by the CSIR and are listed in Table 28, page 
153. 
 
Compounds I-III exhibited non-dose-responsive inhibition up to 10µg/mL for all three 
cell lines with compound IV exhibiting non-dose-responsive inhibition up to 100µg/mL.  




surprising since this compound, a pentacyclic triterepenoid, is structurally different to the 
other three abietane diterpenoids.  
 
The criteria followed by the CSIR states that compounds with TGI > 50µg/mL are 
regarded as being inactive, TGI ranging between 15µg/mL and 50µg/mL are weakly 
active whilst TGI values between 6.25µg/mL and 15µg/mL are indicative of compounds 
which are moderately active.  Any compound having a TGI value of less that 6.25µg/mL 
for at least two of the three cell lines, is considered to be potent (Fouche et al., 2008).  
According to these criteria, compounds I to III are weakly active towards the melanoma 
cell line (44.71 µg/mL (I), 42.18µg/mL (II) and 44.64µg/mL (III)) while the TGI values 
obtained for the breast (51.20µg/mL, 52.72µg/mL and 81.22µg/mL, respectively) and 
renal (49.10µg/mL, 55.84µg/mL and 53.99µg/mL, respectively) cell lines were only 
slightly above 50µg/mL suggesting that these compounds could also be regarded as 
weakly active anticancer agents against these cell lines (Table 28).  Since I to III are 
regarded as weakly active, slight chemical modifications to the structure may enhance it’s 
anticancer activity.  The chemical modifications could not be carried out in this work 
since the samples isolated were insufficient for chemical derivatisation.   
 
The standard used in the three cell pre-screening method was Etoposide having TGI 
values of >100µg/mL, 36.20µg/mL and 27.00µg/mL for breast (MCF-7), melanoma 
(UACC-62) and renal (TK-10) human cell lines, respectively.  In comparison to the 
standard, compounds I to III were proven to be less active with regard to the renal and 
melanoma cell lines.  Compounds II and III displayed TGI values of 55.84µg/mL and 
53.99ug/mL respectively for the renal cell line.  These values are twice that of etoposide 
having a TGI value of 27.00µg/mL against the same cell line.  Compounds I to III were 
found to be more active against the breast cell line than the control with compounds I and 
II having TGI values measuring half at most of that of etoposide with values of 
51.20µg/mL and 52.72µg/mL, respectively.  
 
Compounds I to III inhibited the growth of the melanoma cell line (UACC-62) more than 




whereas GI50 values for the renal and breast cell lines ranged between 21.02µg/mL and 
26.50µg/mL, and 20.57µg/mL and 39.08µg/mL, repectively.  These GI50 values indicate 






















Cell line 1 (TK-10) Cell line 2 (UACC) Cell line 3 (MCF)
 
Figure 20: Dose response curve for 7β-acetoxy-6β-hydroxyroyleanone (I) against TK-10, 























Cell Line 1 (TK-10) Cell Line 2 (UACC) Cell Line 3 (MCF)
 
Figure 21: Dose response curve for 7β,6β-dihydroxyroyleanone (II) against TK-10, UACC-62 and 

























Cell line 1 (TK-10) Cell line 2 (UACC) Cell line 3 (MCF)
 
Figure 22: Dose response curve for ent-pimara-8(14),15-diene-3β,11α-diol (III) against TK-
10, UACC-62 and MCF-7 cell lines  
 
Compound IV, the only triterpenoid tested was only capable of inhibiting the growth 
(GI50) of the melanoma and breast cancer cell lines at concentrations which classified this 























Cell Line 1 (TK-10) Cell Line 2 (UACC) Cell Line 3 (MCF)
 
Figure 23: Dose response curve for 2α,3α,19α-trihydroxyurs-12-en-28-oic acid (IV) against TK-10, 
UACC-62 and MCF-7 cell lines  




Table 28: Growth inhibition values for compounds I-IV against TK-10, UACC-62 















GI50 21.02 13.42 20.57 
TGI 49.10 44.71 51.20 
LC50 77.18 76.00 81.84 
LC100 N/A N/A N/A 
II 
GI50 24.06 12.05 23.63 
TGI 55.84 42.18 52.72 
LC50 87.63 72.32 81.82 
LC100 N/A N/A N/A 
III 
GI50 26.50 13.53 39.08 
TGI 53.99 44.64 81.22 
LC50 81.48 75.74 N/A 
LC100 N/A N/A N/A 
IV 
GI50 N/A 48.67 92.57 
TGI N/A N/A N/A 
LC50 N/A N/A N/A 
LC100 N/A N/A N/A 
Etoposide TGI 27.00 36.20 >100 
NB. N/A denotes inactivity   
 
The GI50 values for compounds I and II are compared to that of their isomers (Gaspar-
Marques et al., 2002) in Table 29. In our results, the GI50 values of both I and II are 
similar.  However, this is not the case with the GI50 values for the isomers, compounds 33 
and 36 reported in the literature.  Compound 36 displayed significantly better activity 
than any of the other three compounds against the three cell lines used.  Our two 
compounds I and II however showed better activity than the dihydroxy isomer (33).   
 
Table 29: GI50 values (µM) of compounds I and II and their 7α-isomers 
Compound 
Cell line 
MCF-7 TK-10 UACC-62 
I 34.41 53.90 52.74 
36 6.4  7.4  4.5  
II 34.63 69.14 67.90 
33 48.3  107.6  77.9  
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Chapter 5  Conclusion 
 
The aim of this research project was to isolate and identify the compounds extracted from 
Plectranthus hadiensis and to compare the phytochemistry with previous studies as well 
as to test the compounds isolated for antibacterial and anticancer proprties. 
 
According to literature (Abdel-Mogib et al., 2002), abietane diterpenes are the most 
abundantly  occurring compounds in the genus Plectranthus with there being two 
instances where ten triterpenes (oleanolic acid, ursolic acid, betulin, β-sitosterol, 
plectranthoic acid,  plectranthoic acid A, plectranthoic acid B, acetylplectranthoic acid, 
plectranthadiol and hexacosanol) have been isolated (Misra et al., 1971; Razdan et al., 
1982).   
 
Compounds I and II have been isolated only once before (Mehrotra et al., 1989) from 
Coleus zeylanicus which is a synonym for Plectranthus hadiensis.  This is the first report 
of compounds III to VI being isolated from P. hadiensis.  Lupeol has never been isolated 
in the Plectranthus genus, however an isopimarane (7α,18-dihydroxy-isopimara-
8(14),15-diene) was reported in Plectranthus diversus (Rasikari, 2007) and stigmasterol 
has been isolated twice before, once from Coleus and once from Plectranthus.   
 
Three of the six compounds isolated from P. hadiensis, (7β-acetoxy-6β-
hydroxyroyleanone (I), 7β,6β-dihydroxyroyleanone (II) and ent-pimara-8(14),15-diene-
3β,11α-diol (III)) were abietanes while the other three were common pentacyclic 
triterpenes known as euscaphic acid (IV), stigmasterol (V) and lupeol (VI).  These three 
triterpenoids add to the ten previously isolated from the Plectranthus species.  Even 
though ethyl acetate and methanol were used as extraction solvents, nothing of interest 
was isolated from these solvents.  The relatively non-polar hexane extract yielded five of 
the six compounds with euscaphic acid IV being isolated from the dichloromethane 
extract.  The isolation of triterpenoids in P. hadiensis is not surprising as most plant 




The isolation of a pimarane in Plectranthus was an interesting find as pimarane-type 
diterpenes are abundant in the Lamiaceae family (to which Plectranthus belongs) being 
found predominantly in the Salvia and Nepeta genera and to a lesser extent in the 
Rabdosia, Callicarpa, Premna, Amaracus, Orthosipho and Satureja genera (Alvarenga et 
al., 2001).  The finding of a pimarane from Plectranthus may now provide a biochemical 
link between Plectranthus and these genera. Pimarane-type diterpenes have also been 
isolated from the Erythroxylum genus (Ansell, 1989) which suggests a link between the 
Lamiaceae family to which Plectranthus is a member of and the Erythroxylaceae to 
which Erythroxylum belongs. 
   
Compounds I and II showed good activity against Enterococcus faecalis and 
Pseudomonas aeruginosa with MICs for compound I being 62.5µg/mL against both 
bacterial strains and that of compound II being 31.30µg/mL and 7.8µg/mL for E. faecalis 
and P. aeruginosa, respectively.  This result is unexpected as royleanones having a highly 
oxidised substituent at C-7 (such as the acetyl group in compound I) are usually more 
active than those bearing a hydroxyl group at positions C-6 and C-7 (Teixeira et al., 
1997; Gaspar-Marques et al., 2006).  The pimarane, ent-pimara-8(14),15-diene-3β,11α-
diol (III), although inactive against E. faecalis was very active against P. aeruginosa.  
 
Based on criteria set by the CSIR where the total growth inhibition (TGI) value is used to 
evaluate the anticancer activity of compounds, compounds I to III are considered to be 
weakly active against breast (MCF-7), renal (TK-10) and melanoma (UACC-62) cell 
lines.  However when compared to the positive control, etoposide, compounds I to III 
exhibit better antitumor activity against the breast cell line than the control.  Compound 
IV was inactive against all three cell lines.   
 
Because compounds I to IV showed weak activity in the three cell prescreen against the 
breast, renal and melanoma cell lines, there was no need to to pursue further anticancer 
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